<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Parkinsons Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Parkinsons Dis</journal-id><journal-id journal-id-type="publisher-id">JPD</journal-id><journal-title-group><journal-title>Journal of Parkinson's Disease</journal-title></journal-title-group><issn pub-type="ppub">1877-7171</issn><issn pub-type="epub">1877-718X</issn><issn-l>1877-7171</issn-l><publisher><publisher-name>IOS Press</publisher-name><publisher-loc>Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6218140</article-id><article-id pub-id-type="publisher-id">JPD181353</article-id><article-id pub-id-type="doi">10.3233/JPD-181353</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Modeling Parkinson&#x02019;s Disease Using Patient-specific Induced Pluripotent Stem Cells</article-title><alt-title alt-title-type="left-running-head">H. Li et al.</alt-title><alt-title alt-title-type="right-running-head">iPSC Models of PD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Houbo</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Boyang</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="aff" rid="aff2">b</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="aff1"><label>a</label>
<institution>Veterans Affairs Western New York Healthcare System</institution>, Buffalo, NY, <country>USA</country>
</aff><aff id="aff2"><label>b</label>Department of Physiology and Biophysics, <institution>State University of New York at Buffalo</institution>, Buffalo, NY, <country>USA</country>
</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to: Jian Feng, PhD, Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214, USA. E-mail: <email>jianfeng@buffalo.edu</email>.
</corresp></author-notes><pub-date date-type="preprint" publication-format="electronic"><day>20</day><month>8</month><year>2018</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>10</month><year>2018</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2018</year></pub-date><volume>8</volume><issue>4</issue><fpage>479</fpage><lpage>493</lpage><history><date date-type="accepted"><day>25</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 &#x02013; IOS Press and the authors. All rights reserved</copyright-statement><copyright-year>2018</copyright-year><license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License</ext-link>, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Parkinson&#x02019;s disease (PD) is the second most common neurodegenerative disorder. It is characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of cases are idiopathic, without a clear etiology, mutations in many genes have been linked to rare, familial forms of PD. It has been quite challenging to develop effective animal models of PD that capture salient features of PD. The discovery of induced pluripotent stem cells (iPSCs) makes it possible to generate patient-specific DA neurons to study PD. Here, we review the methods for the generation of iPSCs and discuss previous studies using iPSC-derived neurons from monogenic forms of PD. These investigations have revealed several converging pathways that intersect with the unique vulnerabilities of human nigral DA neurons. With the rapid development in stem cell biology, it is possible to generate patient-specific neurons that will be increasingly similar to those in the brain of the patient. Combined with the ability to edit the genome to generate isogenic iPSCs, the generation and analysis of patient-specific midbrain DA neurons will transform PD research by providing a valuable tool for mechanistic study and drug discovery.</p></abstract><kwd-group><label>Keywords</label><kwd>iPSC</kwd><kwd>pluripotent</kwd><kwd>stem cells</kwd><kwd>dopaminergic neurons</kwd><kwd>parkin</kwd><kwd><italic>&#x003b1;</italic>-synuclein</kwd><kwd>PINK1</kwd><kwd>DJ-1</kwd><kwd>LRRK2</kwd><kwd>GBA</kwd></kwd-group></article-meta></front><body><sec id="sec0095"><title>INTRODUCTION</title><p>Parkinson&#x02019;s disease (PD) is the second most common neurodegenerative disorder after Alzheimer&#x02019;s disease. PD incidence increases with age; its incidence is 1.5% among population over the age of 55, 1.8% among people over the age of 65 and 2.5% among population over the age of 70 [<xref rid="ref001" ref-type="bibr">1</xref>]. With increasing longevity worldwide, the societal impact of PD will become more severe. PD patients typically suffer from debilitating motor deficits such as tremor, limb rigidity and slowness of movements (bradykinesia) [<xref rid="ref002" ref-type="bibr">2</xref>]. They often also have non-motor symptoms such as dementia, depression, sleep disorders, constipation, loss of smell, etc. [<xref rid="ref003" ref-type="bibr">3</xref>]. Neuropathologically, PD is defined by the progressive loss of dopaminergic (DA) neurons in substantia nigra pars compacta. Approximately 90% of PD cases are idiopathic, without a clear family history. By studying patients with rare, familial forms of PD, mutations in a number of genes have been linked to PD [<xref rid="ref004" ref-type="bibr">4</xref>]. Among these genes, mutations of leucine-rich repeat kinase 2 (<italic>LRRK2</italic>), <italic>SNCA</italic> (encoding <italic>&#x003b1;</italic>-synuclein), Vacuolar Protein Sorting 35 (<italic>VPS35</italic>) have been linked to autosomal dominant PD, whereas mutations of <italic>PARK2</italic> (encoding Parkin), PTEN-induced putative kinase (<italic>PINK1</italic>) and <italic>PARK7</italic> (encoding DJ-1) cause autosomal recessive PD [<xref rid="ref005" ref-type="bibr">5</xref>]. Despite the identification of these genetic mutations, the lack of a clear understanding on how these mutations cause PD hampers the development of disease-modifying therapies.</p><p>One major barrier to PD research is the lack of live brain tissue for invasive studies, such as experiments that require the destruction of live cells to analyze cellular components. As a substitute, the field has been relying on animal models of PD. Pharmacological ablation of nigral DA neurons in animal models of PD has been very useful in studying the degeneration of nigral DA neurons, but they do not reproduce the complex phenotypes seen in PD [<xref rid="ref006" ref-type="bibr">6, 7</xref>]. Genetic mouse models of PD have significant challenges in recapitulating the selective degeneration of nigral DA neurons in PD patients [<xref rid="ref008" ref-type="bibr">8</xref>]. Patient-specific induced pluripotent stem cells (iPSCs) represent a very useful and complementary approach to studying PD [<xref rid="ref009" ref-type="bibr">9</xref>]. Neurons derived from iPSCs of patients with monogenic forms of PD can be used to study how mutations of a single gene generate PD-relevant phenotypes. Such information, taken together with those generated from other approaches, such as animal models and immortalized cell lines, has revealed important insights on mechanisms of PD pathogenesis. Based on mechanistic understanding of PD, a drug discovery program can be implemented on patient-specific neurons to identify agents that are protective against PD phenotypes. The discussions below explore some of these possibilities that are now available to PD research and drug discovery.</p><sec id="sec0100"><title>Generation of iPSCs</title><p>The discovery of induced pluripotency is a landmark breakthrough [<xref rid="ref010" ref-type="bibr">10</xref>] that enables the conversion of easily accessible types of human somatic cells, such as skin or blood cells, into iPSCs. Shinya Yamanaka and colleagues make the initial discovery in 2006 by using retroviral transduction of Oct4, Sox2, Klf4 and c-myc (known as Yamanaka factors) into mouse embryonic fibroblasts or tail fibroblasts. Overexpression of Yamanaka factors reprograms the epigenome of the cells from that of a fibroblast to a pluripotent state and generates iPSCs [<xref rid="ref011" ref-type="bibr">11</xref>]. Subsequently, adult human dermal fibroblasts are reprogrammed to iPSCs with the same method in 2007 [<xref rid="ref012" ref-type="bibr">12</xref>]. These experiments have galvanized stem cell research by making it possible to use patient-specific iPSC-derived cells to study human diseases. Gene expression studies and functional studies show that variations between different lines of human embryonic stem cells (hESCs) and variations between different lines of iPSCs have significant overlap. For virtually all practical purposes, iPSCs and hESCs are essentially equivalent [<xref rid="ref013" ref-type="bibr">13</xref>]. Two main advantages of iPSCs are that they avoid the destruction of human embryos and can be generated from readily available cells from any donors.</p></sec><sec id="sec0105"><title>Generation of footprint-free iPSCs</title><p>Reprogramming methods that utilize retrovirus, lentivirus, or transposon introduce transgenes into the genome of the cells being reprogrammed. It carries the risk of insertional mutations and oncogenic transformation, as both c-Myc and Klf4 are oncogenes. Several methods have been developed to reprogram somatic cells to iPSCs without genomic integration, generating footprint-free iPSCs that have the same genome as the original source cells. Using non-integrating episomal plasmids that support prolonged expression of foreign genes, Yamanaka&#x02019;s group has developed a simple and robust method to reprogram human somatic cells (e.g., human fibroblasts) to iPSCs [<xref rid="ref014" ref-type="bibr">14</xref>]. Similarly, a plasmid of &#x0201c;minicircle&#x0201d; DNA that contains a single cassette of four reprogramming factors (Oct4, Sox2, Lin28, Nanog) plus a green fluorescent protein (GFP) reporter gene is used to reprogram human somatic cells to iPSCs [<xref rid="ref015" ref-type="bibr">15</xref>]. Modified RNAs encoding the four Yamanaka factors have been used to reprogram multiple human cell types to pluripotency [<xref rid="ref016" ref-type="bibr">16</xref>]. Another strategy is to use recombinant proteins. For example, iPSCs are generated from human fibroblasts by directly delivering four reprogramming proteins (Oct4, Sox2, Klf4, and c-Myc) fused with a cell penetrating peptide [<xref rid="ref017" ref-type="bibr">17</xref>]. Similarly, purified recombinant Oct4 and Sox2 fused with the cell-penetrant TAT peptide are used to generate iPSCs for clinical applications [<xref rid="ref018" ref-type="bibr">18, 19</xref>], as the reprogramming factors do not include any oncogenes and only transiently modify the epigenome of the source cells. Some integration-free viruses, such as adeno-associated viruses (AAV) [<xref rid="ref020" ref-type="bibr">20</xref>] and Sendai Virus (SeV) [<xref rid="ref021" ref-type="bibr">21</xref>], are used in iPSC derivation. Both these viruses will be gradually diluted and degraded with each cell division. These footprint-free reprogramming methods provide many options for a variety of applications, depending on the circumstances.</p></sec><sec id="sec0110"><title>Xeno-free iPSCs</title><p>Human iPSCs and hESCs are routinely cultured on mouse embryonic fibroblast feeders. The presence of animal-derived components, which may contain pathogens found in animals, pose unacceptable risks for clinical applications such as transplantation of iPSC-derived cells. Much effort has been directed at establishing xeno-free conditions for the derivation and culture of human iPSCs [<xref rid="ref022" ref-type="bibr">22, 23</xref>]. Cell culture plates can be coated with a xeno-free medium containing high concentrations of basic fibroblast growth factor and fibronectin [<xref rid="ref024" ref-type="bibr">24</xref>]. Xeno-free synthetic culture plates are used in the production of clinical grade iPSCs and their subsequent differentiation to retina cells [<xref rid="ref025" ref-type="bibr">25</xref>]. Combined with vitronectin as an extracellular matrix, a formulated medium with inhibitors of protein kinase C and histone deacetylases maintains long-term culture of xeno-free iPSCs [<xref rid="ref026" ref-type="bibr">26</xref>]. Okano&#x02019;s group establishes a procedure to obtain xeno-free and self-renewing neuroepithelial-like stem cells from feeder-free human iPSCs using a xeno-free medium. The neuroepithelial-like stem cells are cultured for long periods in the medium and can be cryopreserved using a defined serum-free freezing reagent for massive cell banking [<xref rid="ref027" ref-type="bibr">27</xref>]. The dual use of E8 medium and vitronectin-coated culture surfaces can also be employed to derive and culture xeno-free human iPSCs [<xref rid="ref028" ref-type="bibr">28</xref>]. A detailed protocol has been published on how to produce a consistent E8 medium for the derivation, maintenance, expansion and cryopreservation of iPSCs [<xref rid="ref029" ref-type="bibr">29</xref>].</p></sec></sec><sec id="sec0115"><title>MODELING PD USING iPSCs</title><p>The past 20 years witness remarkable discoveries of the genetic influences on PD. Inherited mutations that cause familial PD have been identified in over 18 genes, collectively accounting for about 10% of all PD patients [<xref rid="ref030" ref-type="bibr">30, 31</xref>]. The rest of PD cases are idiopathic, with unclear etiology. Somatic cells (usually skin fibroblasts) from PD patients are reprogrammed to iPSCs, which are differentiated to midbrain DA neurons. Using iPSC-derived DA neurons from PD patients with mutations in a certain gene, many investigators are uncovering mechanistic insights on how mutations of these genes are linked to PD. Here, we review the generation and analysis of patient-specific midbrain DA neurons as models of PD (see <xref rid="jpd-8-jpd181353-t001" ref-type="table">Table 1</xref> for summary), with a brief discussion on the use of patient-specific glial cells.</p><table-wrap id="jpd-8-jpd181353-t001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Phenotypes in iPSCs-derived neurons from monogenic forms of PD</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><th rowspan="1" colspan="1">Protein/Gene</th><th rowspan="1" colspan="1">Mutation</th><th rowspan="1" colspan="1">Phenotype</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>&#x003b1;</italic>-synuclein/<italic>SNCA</italic></td><td rowspan="1" colspan="1"><italic>SNCA</italic> triplication [<xref rid="ref054" ref-type="bibr">54, 55</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Elevated <italic>&#x003b1;</italic>-synuclein levels</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><italic>SNCA</italic> triplication [<xref rid="ref056" ref-type="bibr">56</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0005"><list-item id="listitem0005"><label>&#x02022;</label><p>Elevated <italic>&#x003b1;</italic>-synuclein levels</p></list-item><list-item id="listitem0010"><label>&#x02022;</label><p>Decreased neuronal activity</p></list-item><list-item id="listitem0015"><label>&#x02022;</label><p>Decreased mRNA expression of NURR1, GIRK-2, TH</p></list-item><list-item id="listitem0020"><label>&#x02022;</label><p>Reduced neurite outgrowth</p></list-item><list-item id="listitem0025"><label>&#x02022;</label><p>Increased autophagic flux when stressed with chloroquine</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">A53T [<xref rid="ref059" ref-type="bibr">59</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Nitrosative stress and endoplasmic reticulum stress</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">A53T [<xref rid="ref060" ref-type="bibr">60</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0010"><list-item id="listitem0030"><label>&#x02022;</label><p>Aggregation of <italic>&#x003b1;</italic>-synuclein</p></list-item><list-item id="listitem0035"><label>&#x02022;</label><p>Increased basal levels of reactive oxygen and nitrogen species</p></list-item><list-item id="listitem0040"><label>&#x02022;</label><p>Increased S-nitrosylation of MEF2C (anti-apoptotic transcription factor) upon toxin exposure</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1">LRRK2/<italic>LRRK2</italic></td><td rowspan="1" colspan="1">G2019S [<xref rid="ref073" ref-type="bibr">73</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0015"><list-item id="listitem0045"><label>&#x02022;</label><p>Elevated <italic>&#x003b1;</italic>-synuclein levels</p></list-item><list-item id="listitem0050"><label>&#x02022;</label><p>Increased susceptibility to stress agents: H<sub>2</sub>O<sub>2</sub>, 6-OHDA, and MG-132</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">G2019S [<xref rid="ref074" ref-type="bibr">74</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Increased phosphorylation and activation of ERK1/2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">G2019S [<xref rid="ref075" ref-type="bibr">75, 76</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Reduced amount of neurites and neurite aborization</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">G2019S [<xref rid="ref077" ref-type="bibr">77, 78</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Increased mitochondrial DNA damage and delayed initiation of mitophagy</td></tr><tr><td rowspan="1" colspan="1">Parkin/<italic>PARK2</italic></td><td rowspan="1" colspan="1">Deletions of exon 3 and/or exon 5 [<xref rid="ref091" ref-type="bibr">91, 94, 96</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0020"><list-item id="listitem0055"><label>&#x02022;</label><p>Increased expression of MAOA and MAOB</p></list-item><list-item id="listitem0060"><label>&#x02022;</label><p>Increased spontaneous dopamine release and decreased dopamine reuptake</p></list-item><list-item id="listitem0065"><label>&#x02022;</label><p>Increased bursting of spontaneous excitatory postsynaptic currents</p></list-item><list-item id="listitem0070"><label>&#x02022;</label><p>Reduced neurite length and complexity</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Deletion of exons 2&#x02013;4 or exons 6-7 [<xref rid="ref092" ref-type="bibr">92</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Elevated <italic>&#x003b1;</italic>-synuclein levels</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">V324A [<xref rid="ref093" ref-type="bibr">93</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Abnormal mitochondrial morphology and/or function</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Deletion of exon 3 or exons 3-4 [<xref rid="ref099" ref-type="bibr">99</xref>]</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R275W or R42P [<xref rid="ref099" ref-type="bibr">99, 121</xref>]</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PINK1/<italic>PINK1</italic></td><td rowspan="1" colspan="1">Q456Stop [<xref rid="ref093" ref-type="bibr">93</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0025"><list-item id="listitem0075"><label>&#x02022;</label><p>Aggregation of <italic>&#x003b1;</italic>-synuclein</p></list-item><list-item id="listitem0080"><label>&#x02022;</label><p>Abnormal mitochondrial morphology</p></list-item><list-item id="listitem0085"><label>&#x02022;</label><p>Elevated cytosolic dopamine levels</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">V170G [<xref rid="ref106" ref-type="bibr">106, 108</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Impaired stress-induced recruitment of parkin to mitochondria</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Q456Stop [<xref rid="ref108" ref-type="bibr">108</xref>]</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Q456Stop [<xref rid="ref109" ref-type="bibr">109</xref>]</td><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02002;&#x000a0;&#x02022; Decreased mitochondrial membrane potential and ATP content</td></tr><tr><td rowspan="1" colspan="1">DJ-1/<italic>PARK7</italic></td><td rowspan="1" colspan="1">E64D [<xref rid="ref114" ref-type="bibr">114</xref>]</td><td rowspan="1" colspan="1">
<list list-type="simple" id="list0030"><list-item id="listitem0090"><label>&#x02022;</label><p>Elevated <italic>&#x003b1;</italic>-synuclein levels</p></list-item><list-item id="listitem0095"><label>&#x02022;</label><p>Increased dopamine oxidation and neuromelanin-like pigmented aggregates</p></list-item><list-item id="listitem0100"><label>&#x02022;</label><p>Decreased activity of glucocerebrosidase</p></list-item></list></td></tr></tbody></table><table-wrap-foot><p>Common phenotypes caused by mutations in different genes are grouped in colors with the same color scheme in <xref ref-type="fig" rid="jpd-8-jpd181353-g001">Fig. 1</xref>. References are cited in square brackets.</p></table-wrap-foot></table-wrap><fig id="jpd-8-jpd181353-g001" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Five PD-linked genes converge on three pathways to protect against vulnerabilities of nigral DA neurons. Proteins encoded by five PD-linked genes (<italic>&#x003b1;</italic>-synuclein, LRRK2, parkin, PINK1 and DJ-1) limit oxidative stress stemming from dopamine metabolism and mitochondrial dysfunction (Pathway 1). <italic>&#x003b1;</italic>-synuclein, LRRK2 and parkin maintain the length and complexity of neuronal processes, e.g., through microtubule stabilization (Pathway 2). DJ-1, PINK1, <italic>&#x003b1;</italic>-synuclein, LRRK2 and parkin normally function to prevent the accumulation of <italic>&#x003b1;</italic>-synuclein (Pathway 3). DOPAL, 3,4-Dihydroxyphenylacetaldehyde; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide.</p></caption><graphic xlink:href="jpd-8-jpd181353-g001"/></fig><sec id="sec0120"><title><italic>&#x003b1;</italic>-synuclein</title><p><italic>&#x003b1;</italic>-synuclein, encoded by SNCA gene, is a synaptic vesicle protein that has been shown to negatively regulate dopamine and norepinephrine release. Neurons from mice lacking <italic>&#x003b1;</italic>-synuclein are able to recover quicker (i.e., release more catecholamines) from repetitive stimulation compared to wild-type neurons [<xref rid="ref032" ref-type="bibr">32&#x02013;34</xref>]. This could be related to <italic>&#x003b1;</italic>-synuclein&#x02019;s role as a potent inhibitor of phospholipase D2, which converts phosphatidylcholine to phosphatidic acid and diacyglycerol, both of which positively regulate neurotransmitter release [<xref rid="ref032" ref-type="bibr">32, 35</xref>]. While <italic>&#x003b1;</italic>-synuclein has been shown to be a chaperone <italic>in vitro</italic>; paradoxically, it is a main component of Lewy bodies&#x02014;intracellular protein aggregates found in brains of patients with PD and other neurodegenerative disorders [<xref rid="ref037" ref-type="bibr">37</xref>]. More in-depth discussions of the function of <italic>&#x003b1;</italic>-synuclein can be found in many excellent reviews [<xref rid="ref038" ref-type="bibr">38, 39</xref>].</p><p>Missense mutations (A30P [<xref rid="ref040" ref-type="bibr">40&#x02013;42</xref>], A53E [<xref rid="ref043" ref-type="bibr">43, 44</xref>], A53T [<xref rid="ref045" ref-type="bibr">45</xref>], A53V [<xref rid="ref044" ref-type="bibr">44</xref>], E46K [<xref rid="ref046" ref-type="bibr">46</xref>], G51D [<xref rid="ref047" ref-type="bibr">47&#x02013;49</xref>], H50Q [<xref rid="ref050" ref-type="bibr">50</xref>]) and copy number variations (duplication or triplication) of <italic>SNCA</italic> have been reported in PD patients [<xref rid="ref051" ref-type="bibr">51, 52</xref>]. Genome-wide association studies identify <italic>SNCA</italic> as one of the genes associated with idiopathic PD, suggesting that changes in the expression level of <italic>SNCA</italic> may contribute to idiopathic PD [<xref rid="ref053" ref-type="bibr">53</xref>]. Missense mutations of <italic>&#x003b1;</italic>-synuclein or its overexpression by copy number variations cause misfolding of the protein and its aggregation in Lewy bodies [<xref rid="ref037" ref-type="bibr">37</xref>].</p><p>In DA neurons differentiated from iPSCs of PD patients with <italic>SNCA</italic> triplication mutation, the level of <italic>&#x003b1;</italic>-synuclein protein is twice the amount as that in neurons derived from normal iPSCs [<xref rid="ref054" ref-type="bibr">54</xref>]. An independent study using iPSCs with <italic>SNCA</italic> triplication confirms the increased expression level of <italic>&#x003b1;</italic>-synuclein and demonstrates increased oxidative stress in these DA neurons [<xref rid="ref055" ref-type="bibr">55</xref>]. Neurons with <italic>SNCA</italic> triplication display normal cellular and mitochondrial morphology but substantial changes in growth, viability, cellular energy metabolism and stress resistance, especially when challenged with starvation or toxins [<xref rid="ref056" ref-type="bibr">56</xref>]. Another study finds that SNCA triplication in iPSC-derived neural precursor cells leads to a reduced capacity to differentiate into DA neurons, decreased neurite outgrowth and lower neuronal activity compared to normal neurons. The delayed maturation phenotype is accompanied by a significant reduction in the mRNA level of nuclear receptor related 1 protein (NURR1), G-protein-regulated inward-rectifier potassium channel 2 (GIRK-2) and tyrosine hydroxylase (TH) [<xref rid="ref057" ref-type="bibr">57</xref>].</p><p>To remove potentially confounding influence of different genetic backgrounds when comparing PD patients and normal subjects, isogenic pairs of iPSCs with or without the A53T point mutation of <italic>&#x003b1;</italic>-synuclein are generated using zinc-finger nuclease-mediated genomic editing to introduce the mutation to normal iPSCs or to correct the mutation in patient iPSCs [<xref rid="ref058" ref-type="bibr">58</xref>]. The correction of A53T mutation reverses nitrosative stress and endoplasmic reticulum stress in iPSC-derived neurons [<xref rid="ref059" ref-type="bibr">59</xref>]. In the presence of A53T mutation, increased S-nitrosylation of the transcription factor MEF2C affects the transcriptional regulation of mitochondrial functions by PGC1<italic>&#x003b1;</italic>, a master regulator of mitochondrial biogenesis. Activation of this pathway by A53T mutation increases apoptotic cell death in iPSC-derived midbrain DA neurons [<xref rid="ref060" ref-type="bibr">60</xref>]. Blocking the pathway by isoxazole, a small-molecule compound identified in a high-throughput screen using these isogenic iPSC-derived neurons, protects against the toxicity of environmental PD toxins that target mitochondria [<xref rid="ref060" ref-type="bibr">60</xref>].</p><p>In addition to mutations of <italic>SNCA</italic>, isogenic iPSCs have been generated to study the impact of various single nucleotide polymorphisms identified in genome-wide association studies of idiopathic PD patients. Using CRISPR/Cas9-mediated genomic editing, isogenic pairs of iPSCs with different SNPs are generated. This strategy enables the identification of a distal enhancer in intron 4 of the human <italic>SNCA</italic> gene. A G allele in an SNP in this enhancer decreases the recruitment of brain-specific transcription factors EMX2 and NKX6-1. This increases the interaction of the enhancer with the promoter of <italic>SNCA</italic> and thus elevates the expression level of <italic>SNCA</italic> [<xref rid="ref061" ref-type="bibr">61</xref>].</p></sec><sec id="sec0125"><title>Leucine-rich repeat kinase 2 (LRRK2)</title><p>The <italic>LRRK2</italic> gene encodes a protein with the same name that possesses both kinase and GTPase activities surrounded by protein-interacting domains. Being a multi-domain protein, it is perhaps unsurprising for LRRK2 to have pleiotropic roles in nature. For instance, LRRK2 has been identified to influence outgrowth of neurons [<xref rid="ref062" ref-type="bibr">62</xref>] possibly through its phosphorylation of ERM proteins [<xref rid="ref063" ref-type="bibr">63</xref>] and tubulin [<xref rid="ref064" ref-type="bibr">64</xref>]. Neurite growth may be associated with the role of LRRK2 in macroautophagy [<xref rid="ref065" ref-type="bibr">65</xref>]. Furthermore, through its interaction with Rab5b and Rab7, LRRK2 has been shown to modulate synaptic vesicle endocytosis and endocytic membrane trafficking, respectively [<xref rid="ref066" ref-type="bibr">66, 67</xref>]. The functions of LRRK2 are covered in many excellent reviews [<xref rid="ref068" ref-type="bibr">68, 69</xref>].</p><p>Missense mutations in the <italic>LRRK2</italic> gene are the most common genetic cause of PD. The <italic>LRRK2</italic> G2019S mutation (c.G6055&#x0003e;A) is found in 4% of familial cases and 1% of sporadic cases worldwide. Penetrance of <italic>LRRK2</italic> mutations is age-dependent and estimated to be 24&#x02013;26% in two large scale studies [<xref rid="ref070" ref-type="bibr">70, 71</xref>]. The most frequent <italic>LRRK2</italic> mutation G2019S has a very strong founder effect [<xref rid="ref072" ref-type="bibr">72</xref>]. In iPSC-derived DA neurons from PD patients with <italic>LRRK2</italic> G2019S mutation, there is increased expression of key oxidative stress response genes and <italic>&#x003b1;</italic>-synuclein. Consequently, DA neurons are more sensitive to caspase-3 activation [<xref rid="ref073" ref-type="bibr">73</xref>]. The phenotype on increased oxidative stress is confirmed in an independent study [<xref rid="ref074" ref-type="bibr">74</xref>]. G2019S mutation significantly increases the phosphorylation and activation of extracellular signal regulated kinase 1/2 (ERK1/2) in iPSC-derived DA neurons. Application of the MEK inhibitor PD0325901, which blocks ERK activation, rescues iPSC-derived neurons from degeneration and reduces cell death under oxidative stress [<xref rid="ref074" ref-type="bibr">74</xref>]. The phenotype on increased expression of <italic>&#x003b1;</italic>-synuclein [<xref rid="ref073" ref-type="bibr">73</xref>] is also confirmed in an independent study, which shows that knockdown of <italic>&#x003b1;</italic>-synuclein reduces the toxicity of <italic>LRRK2</italic> G2019S mutation in iPSC-derived DA neurons [<xref rid="ref075" ref-type="bibr">75</xref>]. Two studies independently show that <italic>LRRK2</italic> G2019S mutation significantly reduces the numbers of neurites and neurite arborization [<xref rid="ref076" ref-type="bibr">76</xref>], as well as progressive degeneration of neurites when iPSC-derived neurons mature [<xref rid="ref075" ref-type="bibr">75</xref>]. <italic>LRRK2</italic> G2019S mutation increases mitochondrial DNA damage [<xref rid="ref077" ref-type="bibr">77</xref>] and delays the initiation of mitophagy by affecting the pausing of damaged mitochondria being transported on microtubules [<xref rid="ref078" ref-type="bibr">78</xref>].</p></sec><sec id="sec0130"><title>PARK2</title><p>The <italic>PARK2</italic> gene encodes parkin [<xref rid="ref079" ref-type="bibr">79</xref>], an E3 ligase [<xref rid="ref080" ref-type="bibr">80</xref>] that ubiquitinates a variety of substrates [<xref rid="ref081" ref-type="bibr">81</xref>]. Mutations of parkin are the most frequent cause of recessively inherited PD [<xref rid="ref082" ref-type="bibr">82</xref>]. PD patients with parkin mutations have early onset of PD symptoms; they account for almost 50% of all cases before the age of 45 [<xref rid="ref083" ref-type="bibr">83</xref>]. In contrast to the situation in PD patients with parkin mutations, parkin knockout mice [<xref rid="ref084" ref-type="bibr">84, 85</xref>] or rats [<xref rid="ref086" ref-type="bibr">86</xref>] do not exhibit any significant degeneration of nigral DA neurons or PD-like locomotor symptoms. Our earlier studies in cell lines and neuronal cultures show that parkin suppresses dopamine-induced oxidative stress [<xref rid="ref087" ref-type="bibr">87</xref>] by limiting the transcription of monoamine oxidases (MAO) A and B [<xref rid="ref088" ref-type="bibr">88</xref>] because parkin ubiquitinates and degrades estrogen-related receptors [<xref rid="ref089" ref-type="bibr">89</xref>], a family of nuclear receptors that regulate the transcription of many nuclear-encoded mitochondrial proteins such as MAOs [<xref rid="ref090" ref-type="bibr">90</xref>]. In iPSC-derived midbrain DA neurons that we generate from PD patients with parkin mutations, there is a marked increase of dopamine-induced oxidative stress, as the expression of MAOA and MAOB is significantly elevated [<xref rid="ref091" ref-type="bibr">91</xref>]. Independent studies have confirmed increased oxidative stress in iPSC-derived neurons with parkin mutations [<xref rid="ref092" ref-type="bibr">92, 93</xref>]. We also find that the precision of dopaminergic transmission is significantly disrupted by increased spontaneous DA release and decreased DA reuptake [<xref rid="ref091" ref-type="bibr">91</xref>]. Consistent with this change in neural transmission, dopamine induces oscillatory neuronal activities in iPSC-derived neurons from PD patients with parkin mutations but not from normal subjects [<xref rid="ref094" ref-type="bibr">94</xref>]. This phenotype mirrors widespread rhythmic bursting of neuronal activities in the basal ganglia of PD patients but not of normal subjects or of PD patients on dopaminergic drugs [<xref rid="ref095" ref-type="bibr">95</xref>]. In iPSC-derived neurons, parkin mutations reduce the length and complexity of neuronal processes, particularly those of midbrain DA neurons [<xref rid="ref096" ref-type="bibr">96</xref>]. It is caused by a marked decrease of microtubule stability in neurons with parkin mutations, as the phenotype can be rescued by taxol or overexpression of parkin and can be mimicked in normal neurons treated with colchicine [<xref rid="ref096" ref-type="bibr">96</xref>]. An independent study confirms that parkin mutations reduce microtubule stability in iPSC-derived neurons [<xref rid="ref097" ref-type="bibr">97</xref>].</p><p>With rare exceptions, most PD patients with parkin mutations do not have Lewy bodies [<xref rid="ref098" ref-type="bibr">98</xref>]. In iPSC-derived neurons from two parkin patients, increased accumulation of <italic>&#x003b1;</italic>-synuclein is seen in one patient with Lewy bodies, but not in the other patient without Lewy bodies [<xref rid="ref092" ref-type="bibr">92</xref>]. In our study, there is no significant difference in <italic>&#x003b1;</italic>-synuclein protein levels in iPSC-derived midbrain DA neurons from two PD patients with parkin mutations and two normal subjects [<xref rid="ref091" ref-type="bibr">91</xref>]. Increased levels of <italic>&#x003b1;</italic>-synuclein protein are observed in two other studies using iPSC-derived neurons from PD patients with parkin mutations [<xref rid="ref093" ref-type="bibr">93, 99</xref>].</p><p>Many studies using transfected parkin in cell lines have shown that parkin is recruited to mitochondria to ubiquitinate a variety of substrates for the induction of mitophagy [<xref rid="ref100" ref-type="bibr">100, 101</xref>]. The recruitment of endogenous parkin to mitochondria is not robustly seen in cell lines [<xref rid="ref102" ref-type="bibr">102, 103</xref>], mice [<xref rid="ref104" ref-type="bibr">104, 105</xref>] or iPSC-derived human neurons [<xref rid="ref091" ref-type="bibr">91, 106</xref>]. Although these issues have been extensively reviewed [<xref rid="ref101" ref-type="bibr">101&#x02013;103</xref>], the large body of literature on the role of parkin in mitophagy and the significant interest in the field have led to several independent studies of this issue in iPSC-derived neurons with parkin mutations. Significantly increased percentages of iPSC-derived neurons with abnormal mitochondria (usually with elongated shape and larger volume) are observed in three separate studies [<xref rid="ref092" ref-type="bibr">92, 93, 99</xref>]. However, two different studies using qPCR show that there is no significant change in mitochondria DNA copy number [<xref rid="ref091" ref-type="bibr">91, 92</xref>]. It seems that parkin mutations in iPSC-derived neurons may alter mitochondrial morphology in a portion of the cells, particularly TH<sup>+</sup> neurons [<xref rid="ref099" ref-type="bibr">99</xref>], but the modest changes may be balanced by robust biogenesis of mitochondria.</p></sec><sec id="sec0135"><title>PINK1</title><p>Phosphatase and tensin homolog (PTEN)-induced Putative Kinase 1 (PINK1) is a mitochondria-targeted Ser/Thr protein kinase. Under normal condition, PINK1 is quickly cleaved by proteases on mitochondrial outer membrane and is thus released to cytosol for degradation, which limits the steady state level of PINK1 [<xref rid="ref107" ref-type="bibr">107</xref>]. Insults that depolarize mitochondrial inner membrane arrest the mitochondrial transport of PINK1, which triggers the phosphorylation of parkin on the ubiquitin-like domain and activates the E3 ligase activity of parkin. Mitochondrially recruited parkin ubiquitinates many mitochondrial outer membrane proteins and induces autophagic clearance of depolarized mitochondria [<xref rid="ref101" ref-type="bibr">101</xref>].</p><p>In two separate studies using the same line of iPSC-derived neurons from PD patients with PINK1 mutations, valinomycin-induced mitochondrial recruitment of exogenously expressed parkin is abrogated by PINK1 mutations [<xref rid="ref106" ref-type="bibr">106, 108</xref>]. Loss of PINK1 abolishes the degradation of mitochondrial proteins only in fibroblasts, but not in isogenic iPSC-derived neurons, which do not exhibit significant mitophagy even with parkin overexpression and valinomycin treatment for 16 hours [<xref rid="ref106" ref-type="bibr">106</xref>]. Midbrain DA neurons derived from iPSCs of PD patients with PINK1 mutations exhibit <italic>&#x003b1;</italic>-synuclein accumulation, abnormal mitochondrial morphology and increased cytosolic dopamine levels [<xref rid="ref093" ref-type="bibr">93</xref>]. In iPSC-derived neurons, PINK1 mutations reduce complex I activity, which leads to a reduction in mitochondrial membrane potential. Phosphorylation of Ser250 in NdufA10 regulates the activity of ubiquinone reductase in mitochondrial complex I. A phosphomimetic mutant of NdufA10 reverses the deficiencies in complex I activity and ATP synthesis in iPSC-derived neurons with PINK1 mutations [<xref rid="ref109" ref-type="bibr">109</xref>]. Consistent with this, coenzyme Q10 rescues the cellular vulnerability associated with mitochondrial dysfunction in iPSC-derived neurons from PD patients with PINK1 mutations [<xref rid="ref110" ref-type="bibr">110</xref>]. In a separate study, increased expression of LRRK2 is observed in iPSC-derived neurons with PINK1 mutations [<xref rid="ref111" ref-type="bibr">111</xref>].</p></sec><sec id="sec0140"><title>DJ-1</title><p>Mutations of DJ-1 cause early-onset recessive PD [<xref rid="ref112" ref-type="bibr">112</xref>]. Human DJ-1 is a small protein with 189 amino acid residues, three of which are cysteines. It normally forms a homodimer that exhibits anti-oxidant activities [<xref rid="ref113" ref-type="bibr">113</xref>]. In iPSC-derived midbrain DA neurons from PD patients with homozygous DJ-1 mutations, there are increased dopamine oxidation and neuromelanin-like pigmented aggregates [<xref rid="ref114" ref-type="bibr">114</xref>]. Increased oxidative stress stemming from dopamine metabolism triggers mitochondrial oxidative stress, both of which are significantly attenuated by blocking dopamine synthesis [<xref rid="ref114" ref-type="bibr">114</xref>]. Dopamine-induced oxidative stress inactivates glucocerebrosidase, which inhibits lysosomal functions and leads to increased expression of <italic>&#x003b1;</italic>-synuclein [<xref rid="ref114" ref-type="bibr">114</xref>]. The phenotypes are confirmed in an isogenic pair of iPSC-derived midbrain DA neurons with or without DJ-1 mutations. More interestingly, iPSC-derived normal human midbrain DA neurons have significantly higher level of dopamine than iPSC-derived wild-type mouse midbrain DA neurons. Increasing dopamine level by L-DOPA treatment dramatically elevates dopamine oxidation in iPSC-derived midbrain DA neurons from DJ-1 knockout mice but not neurons derived from wild-type mice [<xref rid="ref114" ref-type="bibr">114</xref>]. Thus, DJ-1 mutations reveal the vulnerability of midbrain DA neurons in handling dopamine-induced oxidative stress, which is more severe in human than in mouse.</p></sec><sec id="sec0145"><title>Risk alleles</title><p>The majority of PD cases do not have any family history and are likely influenced by both environmental and genetic susceptibility factors. With an odds ratio around 5, mutations in the gene encoding glucocerebrosidase (<italic>GBA</italic>) are currently recognized to be the greatest risk factor for PD [<xref rid="ref002" ref-type="bibr">2, 115</xref>]. <italic>GBA</italic> mutations decrease the enzymatic activity of glucocerebrosidase, leading to the accumulation of glucosylceramide and glucosylsphingosine in lysosomes and the potential development of symptoms for Gaucher&#x02019;s disease and PD [<xref rid="ref115" ref-type="bibr">115</xref>]. In iPSC-derived DA neurons from PD patients carrying mutated <italic>GBA</italic>, protein levels and enzymatic activity of glucocerebrosidase are significantly lower, concomitant with higher levels of <italic>&#x003b1;</italic>-synuclein and glucosylceramide compared to isogenic controls [<xref rid="ref116" ref-type="bibr">116</xref>]. These <italic>GBA</italic> mutant neurons also display abnormalities towards the autophagic/lysosomal pathway and calcium homeostasis [<xref rid="ref116" ref-type="bibr">116</xref>]. The association between elevated a-synuclein and diminished glucocerebrosidase activity with GBA mutations has also been reported in a twin study through analyzing their iPSC-derived DA neurons [<xref rid="ref117" ref-type="bibr">117</xref>]. The monozygotic twins are discordant for PD but both heterozygous for a mutated <italic>GBA</italic>. Intriguingly, neurons derived from the affected twin display lower dopamine level and upregulated MAOB expression, compared to the unaffected twin. The study highlights the interplay between genetic and environmental factors in shaping phenotypes.</p><p>With the rise of genome-wide association studies, variants in loci including <italic>SNCA</italic> and <italic>LRKK2</italic> have been confirmed, while others&#x02014;<italic>MAPT</italic>, <italic>VPS13C</italic>, <italic>BST1</italic>, <italic>DDGRK1</italic> and many more&#x02014;have been identified as novel risk factors for PD development [<xref rid="ref002" ref-type="bibr">2</xref>]. To date, iPSC technology has been applied to only a few of these new targets. For example, iPSC-derived neurons from patients with <italic>MAPT</italic> mutations show irregularities in the expression of tau proteins, tau hyperphosphorylation and mitochondrial axonal transport compared to controls [<xref rid="ref118" ref-type="bibr">118</xref>]. Axonal degeneration has also been found in iPSC-derived neurons carrying mutated <italic>MAPT</italic>. Isogenic repair of the mutation restores axonal morphology [<xref rid="ref119" ref-type="bibr">119</xref>].</p></sec><sec id="sec0150"><title>Utilizing iPSC-derived glial cells in modeling PD</title><p>Whether glial cells instigate or react to neuronal death remains to be settled. However, many lines of evidence have implicated the involvement of glia in PD. Neuroinflammation observed in PD patients has been mainly associated with activation of microglial cells, which releases inflammatory cytokines, such as IL-1<italic>&#x003b2;</italic>, IL-6 and TNF-<italic>&#x003b1;</italic> (tumor necrosis factor-<italic>&#x003b1;</italic>). In particular, TNF-<italic>&#x003b1;</italic> is known to trigger neuronal death [<xref rid="ref120" ref-type="bibr">120</xref>]. Elevated levels of TNF-<italic>&#x003b1;</italic> have been found in the brain and cerebrospinal fluid of PD patients [<xref rid="ref121" ref-type="bibr">121</xref>]. Activated microglial cells may also inflict neuronal damage by producing reactive oxygen and nitrogen species [<xref rid="ref122" ref-type="bibr">122</xref>]. Paradoxically, astrocytes and microglial cells secrete growth factors, such as BDNF (brain-derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor), that are critical for neuronal survival [<xref rid="ref122" ref-type="bibr">122, 123</xref>]. Supplementing GDNF to MPTP-treated primate models of PD significantly increases levels of DA neurons and improves PD motor symptoms [<xref rid="ref124" ref-type="bibr">124, 125</xref>]; however, the therapeutic effect of BDNF for PD patients remains to be established [<xref rid="ref126" ref-type="bibr">126</xref>].</p><p>As the complex relationship between glia and neurons is disrupted in PD, co-culturing glial cells and neurons both derived from iPSCs of PD patients should therefore be another platform to advance insights into the multifactorial pathogenesis of PD. For example, <italic>&#x003b1;</italic>-synuclein has been shown to not only impact neurons but also directly activate and induce TNF-<italic>&#x003b1;</italic> release from primary microglial cultures [<xref rid="ref127" ref-type="bibr">127</xref>]. In transgenic mice overexpressing wild-type <italic>&#x003b1;</italic>-synuclein, significantly more activated microglial are observed in the substantia nigra compared to age-matched control mice [<xref rid="ref127" ref-type="bibr">127</xref>]. Moreover, LRKK2 is known to be expressed in microglial. Activating microglial from transgenic mice overexpressing PD-linked LRRK2-R1441G mutation leads to more secretion of inflammatory cytokines compared to those from activated wild-type microglial [<xref rid="ref128" ref-type="bibr">128</xref>].</p><p>Protocols to differentiate hPSCs (human pluripotent stem cells) to astrocytes have been published since the first neural differentiation method in 2001 using FGF-2 (fibroblast growth factor 2) [<xref rid="ref129" ref-type="bibr">129</xref>]. For the majority, embryoid bodies are utilized as starting point. Through various growth factor cocktails, embryoid bodies are differentiated to neuroectodermal derivatives, neural progenitor cells, and finally astrocytes [<xref rid="ref130" ref-type="bibr">130</xref>]. Since microglial are of mesodermal lineage and distinct from astrocytes, IL-34 and CSF1 (colony-stimulating factor 1) have been used to differentiate embryoid bodies into cell lawns resembling endothelial cells (i.e., cystic embryoid bodies) to later become mature microglia-like cells [<xref rid="ref131" ref-type="bibr">131</xref>]. Applications of glial cell differentiation protocols have shed light into the pathogenesis of Alzheimer&#x02019;s disease [<xref rid="ref132" ref-type="bibr">132</xref>] and Huntington&#x02019;s disease [<xref rid="ref133" ref-type="bibr">133</xref>]. Similar studies on PD will undoubtedly improve our understanding of the complex interactions between glia and neurons in PD pathogenesis.</p></sec></sec><sec id="sec0155"><title>CONCLUSIONS</title><p>The discovery of induced pluripotent stem cells has transformed biomedical research by enabling researchers to use the human model system to study diseases. It has been particularly fruitful for PD, as genetic animal models of PD have significant challenges in recapitulating the critical features of PD&#x02014;loss of nigral DA neurons and the ensuing locomotor phenotypes [<xref rid="ref008" ref-type="bibr">8</xref>]. Rapid development in stem cell technology will make the system more useful. One current issue in using iPSC-derived neurons is its immaturity [<xref rid="ref134" ref-type="bibr">134, 135</xref>], which may not adequately reflect age-related disorders such as PD. The use of progerin [<xref rid="ref136" ref-type="bibr">136</xref>] and astrocytes [<xref rid="ref137" ref-type="bibr">137</xref>] allows improved modeling of age-related changes in iPSC-derived neurons. Another approach is to transplant human iPSC-derived neurons in rat brains [<xref rid="ref138" ref-type="bibr">138</xref>] or even brains of non-human primates [<xref rid="ref139" ref-type="bibr">139</xref>], which would enable more effective modeling of age-dependent pathologies. The long-term engraftment of hPSC-derived brain organoids in mouse brains [<xref rid="ref140" ref-type="bibr">140</xref>] offers another novel solution that provides physiological environment <italic>in vivo</italic> to promote the maturation and function of transplanted human neurons.</p><p>From analyzing phenotypes found in iPSC-derived neurons from monogenic forms of PD, several converging pathways appear to intersect with the unique vulnerabilities of human nigral DA neurons (<xref ref-type="fig" rid="jpd-8-jpd181353-g001">Fig. 1</xref>). First, increased oxidative stress is found in iPSC-derived DA neurons from PD patients with <italic>&#x003b1;</italic>-synuclein [<xref rid="ref055" ref-type="bibr">55, 59</xref>], LRRK2 [<xref rid="ref073" ref-type="bibr">73, 74</xref>], parkin [<xref rid="ref091" ref-type="bibr">91&#x02013;93</xref>], PINK1 [<xref rid="ref093" ref-type="bibr">93</xref>] or DJ-1 mutations [<xref rid="ref114" ref-type="bibr">114</xref>]. Mitochondria are the most significant source of oxidative stress, as they handle the catabolic breakdown of dopamine. Monoamine oxidases, which are anchored on mitochondrial outer membrane [<xref rid="ref141" ref-type="bibr">141</xref>], catalyze the oxidative deamination of cytosolic dopamine, a reaction that produces H<sub>2</sub>O<sub>2</sub> and its derivative free radicals. Dopamine-induced oxidative stress is increased by elevated expression of monoamine oxidases when parkin is mutated [<xref rid="ref091" ref-type="bibr">91</xref>]. Mutations of DJ-1 in human midbrain DA neurons increase dopamine-induced oxidative stress, which triggers mitochondrial dysfunction downstream [<xref rid="ref114" ref-type="bibr">114</xref>]. Depolarization of mitochondrial inner membrane potential increases oxidative stress as electrons normally flowing through the mitochondrial respiratory chain are shunted to O<sub>2</sub> in the cell. Ca<sup>2 +</sup>-dependent autonomous pacemaking [<xref rid="ref142" ref-type="bibr">142</xref>] and lack of Ca<sup>2 +</sup> buffer proteins [<xref rid="ref143" ref-type="bibr">143</xref>] exacerbate the stress on mitochondria because they serve as a major store of intracellular Ca<sup>2 +</sup> [<xref rid="ref144" ref-type="bibr">144</xref>]. A significant decrease of mitochondrial inner membrane potential triggers the stabilization of PINK1, which phosphorylates parkin to activate and recruit it to mitochondria, where parkin ubiquitinates many mitochondrial proteins to trigger autophagy [<xref rid="ref101" ref-type="bibr">101</xref>]. Relatively modest morphological or functional changes in mitochondria have been observed in iPSC-derived neurons with parkin mutations [<xref rid="ref092" ref-type="bibr">92, 93, 99</xref>] or PINK1 mutations [<xref rid="ref109" ref-type="bibr">109</xref>]. Several studies show that parkin mutations [<xref rid="ref091" ref-type="bibr">91, 92</xref>] or PINK1 mutations [<xref rid="ref106" ref-type="bibr">106, 108</xref>] do not grossly affect mitochondria copy number, or even mitophagy [<xref rid="ref106" ref-type="bibr">106</xref>]. The different results between iPSC-derived human midbrain DA neurons and immortalized cell lines are not easy to reconcile. One possibility could be that human nigral DA neurons normally increase mitochondrial DNA (mtDNA) copy numbers with age to maintain the amount of wild-type mtDNA despite age-dependent increase of deletion mutations in mtDNA [<xref rid="ref145" ref-type="bibr">145</xref>]. Thus, strong mitochondrial biogenesis in human DA neurons may balance out the modest defects in mitophagy. Further studies are needed to address the role of mitochondria in the selective vulnerability of nigral DA neurons, which paradoxically have significantly lower mitochondrial mass than VTA DA neurons and other non-DA neurons [<xref rid="ref146" ref-type="bibr">146</xref>] and are quite resistant to mutations of mtDNA [<xref rid="ref147" ref-type="bibr">147</xref>].</p><p>Second, reduced neurite length and complexity are found in iPSC-derived neurons from PD patients with mutations in a-synuclein [<xref rid="ref057" ref-type="bibr">57</xref>], LRRK2 [<xref rid="ref075" ref-type="bibr">75, 76</xref>], or parkin [<xref rid="ref096" ref-type="bibr">96, 97</xref>]. This phenotype critically reflects a key vulnerability of nigral DA neurons, which have massive axon arbors. The total length of axon arbors of a single rat nigral DA neuron averages 45 cm [<xref rid="ref148" ref-type="bibr">148</xref>]. It is estimated that a single human nigral DA neuron may have axon arbors with a total length of 4.6 m [<xref rid="ref149" ref-type="bibr">149</xref>], which may make these neurons much more vulnerable than other types of neurons to microtubule disruption [<xref rid="ref150" ref-type="bibr">150</xref>], particularly in human [<xref rid="ref151" ref-type="bibr">151</xref>]. Microtubules not only maintain the morphology and structural integrity of neuronal processes but also serve an obligatory function in the transportation of vesicles, including mitochondria. Abnormal mitochondrial transport has been reported in iPSC-derived neurons from PD patients with LRRK2 G2019S mutation [<xref rid="ref078" ref-type="bibr">78</xref>].</p><p>Third, increased expression of <italic>&#x003b1;</italic>-synuclein has been observed in iPSC-derived neurons from PD patients with mutations in <italic>&#x003b1;</italic>-synuclein [<xref rid="ref054" ref-type="bibr">54, 55</xref>], LRRK2 [<xref rid="ref073" ref-type="bibr">73, 75</xref>], parkin [<xref rid="ref093" ref-type="bibr">93, 99</xref>], PINK1 [<xref rid="ref093" ref-type="bibr">93</xref>] or DJ-1 [<xref rid="ref114" ref-type="bibr">114</xref>]. The significant role of <italic>&#x003b1;</italic>-synuclein in PD has been well documented [<xref rid="ref152" ref-type="bibr">152</xref>]. Debates on whether <italic>&#x003b1;</italic>-synuclein is transmitted between neurons and whether such transmission causes the selective degeneration of nigral DA neurons in PD [<xref rid="ref153" ref-type="bibr">153, 154</xref>] make it very important to generate patient-specific midbrain DA neurons to address these issues. It remains unclear how <italic>&#x003b1;</italic>-synuclein accumulation causes the selective loss of nigral DA neurons. One possibility is that <italic>&#x003b1;</italic>-synuclein increases cytosolic dopamine concentration more significantly in nigral DA neurons than in VTA DA neurons [<xref rid="ref155" ref-type="bibr">155</xref>]. Dopamine-induced oxidative stress, in conjunction with mitochondrial oxidative stress downstream of <italic>&#x003b1;</italic>-synuclein overexpression, may impact nigral DA neurons much more than other types of cells [<xref rid="ref156" ref-type="bibr">156</xref>].</p><p>These three pathways intersect with the unique vulnerabilities of human nigral DA neurons, which produce a large amount of dopamine for controlled release in their massive axon arbors. The need for nigral DA neurons to release an oxidation-prone neurotransmitter in a continuous, autonomous pacemaking manner underlies the vulnerabilities that are revealed by mutations of PD-linked genes. Mechanism-based drug development programs can be implemented to mimic the normal functions of these genes in suppressing oxidative stress, maintaining neuronal morphology and limiting <italic>&#x003b1;</italic>-synuclein expression. Patient-specific iPSC-derived neurons would provide an excellent platform for screening compounds that block the deleterious effects of these mutations. The observation that five different monogenic causes of PD converge on three common pathways suggests that it is possible to use iPSC-derived neurons with different monogenic etiologies to cross-validate hits identified from screens. Isogenic pairs of iPSC-derived neurons can be generated by introducing PD-linked mutations to normal iPSCs or by repairing mutations in patient iPSCs. Such isogenic pairs of iPSC-derived midbrain DA neurons would be an even better platform for screening compounds, as they remove the potentially confounding influence of different genetic backgrounds between normal subjects and PD patients. Furthermore, iPSC-derived midbrain DA neurons from idiopathic PD patients can be used to validate the hits and generate valuable information on how well the findings can be extrapolated to idiopathic PD. This is highly useful and unique to the human model system, where efficacy can be established in patient-specific neurons in a dish to estimate their chance of success in patients. In addition, safety studies can be done on other types of cells (e.g., liver cells or kidney cells) differentiated from the same set of iPSCs. There is an increasing trend for pharmaceutical companies to transition their drug discovery programs to the human model system as embodied in iPSCs. The stage is set for more mechanistic study and drug discovery research on PD based on patient-specific iPSC-derived cells. The future is indeed much brighter with the advent of this transformative technology.</p></sec><sec id="sec0160"><title>CONFLICT OF INTEREST</title><p>The authors declare no competing financial interests.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by National Institute of Neurological Diseases and Stroke grant R56NS102148, Department of Veterans Affairs Merit Awards I01BX002452 and I01BX003831 and New York State Department of Health NYSTEM Contract C029556.</p></ack><ref-list><title>REFERENCES</title><ref id="ref001"><label>[1]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Latourelle</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Pankratz</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dumitriu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wilk</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Goldwurm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pezzoli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mariani</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>DeStefano</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Halter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gusella</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Nichols</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Myers</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Foroud</surname>
<given-names>T</given-names>
</string-name>, <collab>Progeni and GenePd Investigators</collab>
(<year>2009</year>) <article-title>Genomewide association study for onset age in Parkinson disease</article-title>. <source>BMC Med Genet</source>
<volume>10</volume>, <fpage>98</fpage>.<pub-id pub-id-type="pmid">19772629</pub-id></mixed-citation></ref><ref id="ref002"><label>[2]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kalia</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>AE</given-names>
</string-name>
(<year>2015</year>) <article-title>Parkinson&#x02019;s disease</article-title>. <source>Lancet</source>
<volume>386</volume>, <fpage>896</fpage>&#x02013;<lpage>912</lpage>.<pub-id pub-id-type="pmid">25904081</pub-id></mixed-citation></ref><ref id="ref003"><label>[3]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chaudhuri</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Healy</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Schapira</surname>
<given-names>AH</given-names>
</string-name>
(<year>2006</year>) <article-title>Non-motor symptoms of Parkinson&#x02019;s disease: Diagnosis and management</article-title>. <source>Lancet Neurol</source>
<volume>5</volume>, <fpage>235</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">16488379</pub-id></mixed-citation></ref><ref id="ref004"><label>[4]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>Y</given-names>
</string-name>
(<year>2011</year>) <article-title>Milestones in PD genetics</article-title>. <source>Mov Disord</source>
<volume>26</volume>, <fpage>1042</fpage>&#x02013;<lpage>1048</lpage>.<pub-id pub-id-type="pmid">21626549</pub-id></mixed-citation></ref><ref id="ref005"><label>[5]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Singleton</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>
(<year>2016</year>) <article-title>The evolution of genetics: Alzheimer&#x02019;s and Parkinson&#x02019;s diseases</article-title>. <source>Neuron</source>
<volume>90</volume>, <fpage>1154</fpage>&#x02013;<lpage>1163</lpage>.<pub-id pub-id-type="pmid">27311081</pub-id></mixed-citation></ref><ref id="ref006"><label>[6]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Beal</surname>
<given-names>MF</given-names>
</string-name>
(<year>2001</year>) <article-title>Experimental models of Parkinson&#x02019;s disease</article-title>. <source>Nat Rev Neurosci</source>
<volume>2</volume>, <fpage>325</fpage>&#x02013;<lpage>334</lpage>.<pub-id pub-id-type="pmid">11331916</pub-id></mixed-citation></ref><ref id="ref007"><label>[7]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Duty</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jenner</surname>
<given-names>P</given-names>
</string-name>
(<year>2011</year>) <article-title>Animal models of Parkinson&#x02019;s disease: A source of novel treatments and clues to the cause of the disease</article-title>. <source>Br J Pharmacol</source>
<volume>164</volume>, <fpage>1357</fpage>&#x02013;<lpage>1391</lpage>.<pub-id pub-id-type="pmid">21486284</pub-id></mixed-citation></ref><ref id="ref008"><label>[8]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Dawson</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Ko</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>VL</given-names>
</string-name>
(<year>2010</year>) <article-title>Genetic animal models of Parkinson&#x02019;s disease</article-title>. <source>Neuron</source>
<volume>66</volume>, <fpage>646</fpage>&#x02013;<lpage>661</lpage>.<pub-id pub-id-type="pmid">20547124</pub-id></mixed-citation></ref><ref id="ref009"><label>[9]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2012</year>) <article-title>Redefining Parkinson&#x02019;s disease research using induced pluripotent stem cells</article-title>. <source>Curr Neurol Neurosci Rep</source>
<volume>12</volume>, <fpage>392</fpage>&#x02013;<lpage>398</lpage>.<pub-id pub-id-type="pmid">22622410</pub-id></mixed-citation></ref><ref id="ref010"><label>[10]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>
(<year>2013</year>) <article-title>The winding road to pluripotency (Nobel Lecture)</article-title>. <source>Angew Chem Int Ed Engl</source>
<volume>52</volume>, <fpage>13900</fpage>&#x02013;<lpage>13909</lpage>.<pub-id pub-id-type="pmid">24255017</pub-id></mixed-citation></ref><ref id="ref011"><label>[11]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>
(<year>2006</year>) <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>. <source>Cell</source>
<volume>126</volume>, <fpage>663</fpage>&#x02013;<lpage>676</lpage>.<pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation></ref><ref id="ref012"><label>[12]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ohnuki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Narita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ichisaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tomoda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>
(<year>2007</year>) <article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors</article-title>. <source>Cell</source>
<volume>131</volume>, <fpage>861</fpage>&#x02013;<lpage>872</lpage>.<pub-id pub-id-type="pmid">18035408</pub-id></mixed-citation></ref><ref id="ref013"><label>[13]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mallard</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Clement</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tagliazucchi</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>IY</given-names>
</string-name>, <string-name>
<surname>Ferrari</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tsankov</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Pop</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rinn</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Meissner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Hochedlinger</surname>
<given-names>K</given-names>
</string-name>
(<year>2015</year>) <article-title>A comon of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs</article-title>. <source>Nat Biotechnol</source>
<volume>33</volume>, <fpage>1173</fpage>&#x02013;<lpage>1181</lpage>.<pub-id pub-id-type="pmid">26501951</pub-id></mixed-citation></ref><ref id="ref014"><label>[14]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Okita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsumura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Morizane</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tezuka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shibata</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kunisada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Saji</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>
(<year>2011</year>) <article-title>A more efficient method to generate integration-free human iPS cells</article-title>. <source>Nat Methods</source>
<volume>8</volume>, <fpage>409</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="pmid">21460823</pub-id></mixed-citation></ref><ref id="ref015"><label>[15]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jia</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gupta</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Panetta</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Robbins</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Kay</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Longaker</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>JC</given-names>
</string-name>
(<year>2010</year>) <article-title>A nonviral minicircle vector for deriving human iPS cells</article-title>. <source>Nat Methods</source>
<volume>7</volume>, <fpage>197</fpage>&#x02013;<lpage>199</lpage>.<pub-id pub-id-type="pmid">20139967</pub-id></mixed-citation></ref><ref id="ref016"><label>[16]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Warren</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Manos</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Ahfeldt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Loh</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ebina</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Mandal</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>ZD</given-names>
</string-name>, <string-name>
<surname>Meissner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Daley</surname>
<given-names>GQ</given-names>
</string-name>, <string-name>
<surname>Brack</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Cowan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schlaeger</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>DJ</given-names>
</string-name>
(<year>2010</year>) <article-title>Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA</article-title>. <source>Cell Stem Cell</source>
<volume>7</volume>, <fpage>618</fpage>&#x02013;<lpage>630</lpage>.<pub-id pub-id-type="pmid">20888316</pub-id></mixed-citation></ref><ref id="ref017"><label>[17]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Nordin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>
<given-names>RNR</given-names>
</string-name>, <string-name>
<surname>Farzaneh</surname>
<given-names>F</given-names>
</string-name>
(<year>2017</year>) <article-title>Transactivator protein: An alternative for delivery of recombinantroteins for safer reprogramming of induced pluripotent stem cell</article-title>. <source>Virus Res</source>
<volume>235</volume>, <fpage>106</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">28408207</pub-id></mixed-citation></ref><ref id="ref018"><label>[18]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Thier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Munst</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Edenhofer</surname>
<given-names>F</given-names>
</string-name>
(<year>2010</year>) <article-title>Exploring refined conditions for reprogramming cells by recombinant Oct4 protein</article-title>. <source>Int J Dev Biol</source>
<volume>54</volume>, <fpage>1713</fpage>&#x02013;<lpage>1721</lpage>.<pub-id pub-id-type="pmid">21404191</pub-id></mixed-citation></ref><ref id="ref019"><label>[19]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Thier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Munst</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mielke</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Edenhofer</surname>
<given-names>F</given-names>
</string-name>
(<year>2012</year>) <article-title>Cellular reprogramming employing recombinant sox2 protein</article-title>. <source>Stem Cells Int</source>
<volume>2012</volume>, <fpage>549846</fpage>.<pub-id pub-id-type="pmid">22693519</pub-id></mixed-citation></ref><ref id="ref020"><label>[20]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhou</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Freed</surname>
<given-names>CR</given-names>
</string-name>
(<year>2009</year>) <article-title>Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells</article-title>. <source>Stem Cells</source>
<volume>27</volume>, <fpage>2667</fpage>&#x02013;<lpage>2674</lpage>.<pub-id pub-id-type="pmid">19697349</pub-id></mixed-citation></ref><ref id="ref021"><label>[21]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Fusaki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ban</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nishiyama</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Saeki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>M</given-names>
</string-name>
(<year>2009</year>) <article-title>Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome</article-title>. <source>Proc Jpn Acad Ser B Phys Biol Sci</source>
<volume>85</volume>, <fpage>348</fpage>&#x02013;<lpage>362</lpage>.</mixed-citation></ref><ref id="ref022"><label>[22]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Villa-Diaz</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Lahann</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Krebsbach</surname>
<given-names>PH</given-names>
</string-name>
(<year>2013</year>) <article-title>Concise review: The evolution of human pluripotent stem cell culture: From feeder cells to synthetic coatings</article-title>. <source>Stem Cells</source>
<volume>31</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">23081828</pub-id></mixed-citation></ref><ref id="ref023"><label>[23]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ashok</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hsiung</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tzanakakis</surname>
<given-names>ES</given-names>
</string-name>
(<year>2015</year>) <article-title>Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: Progress and challenges</article-title>. <source>Stem Cell Rev</source>
<volume>11</volume>, <fpage>96</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="pmid">25077810</pub-id></mixed-citation></ref><ref id="ref024"><label>[24]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ding</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>DS</given-names>
</string-name>
(<year>2015</year>) <article-title>Feeder-free and xeno-free culture of human pluripotent stem cells using UCBS matrix.</article-title>. <source>Cell Biol Int</source>
<volume>39</volume>, <fpage>1111</fpage>&#x02013;<lpage>1119</lpage>.<pub-id pub-id-type="pmid">25939663</pub-id></mixed-citation></ref><ref id="ref025"><label>[25]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Tucker</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Anfinson</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Mullins</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Stone</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>MJ</given-names>
</string-name>
(<year>2013</year>) <article-title>Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation</article-title>. <source>Stem Cells Transl Med</source>
<volume>2</volume>, <fpage>16</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">23283489</pub-id></mixed-citation></ref><ref id="ref026"><label>[26]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>
<given-names>DY</given-names>
</string-name>
(<year>2013</year>) <article-title>An ECM-based culture system for the generation and maintenance of xeno-free human iPS cells</article-title>. <source>Biomaterials</source>
<volume>34</volume>, <fpage>1041</fpage>&#x02013;<lpage>1050</lpage>.<pub-id pub-id-type="pmid">23153417</pub-id></mixed-citation></ref><ref id="ref027"><label>[27]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Isoda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kohyama</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Iwanami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sanosaka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sugai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Okano</surname>
<given-names>H</given-names>
</string-name>
(<year>2016</year>) <article-title>Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions</article-title>. <source>Neurosci Res</source>
<volume>110</volume>, <fpage>18</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">27083781</pub-id></mixed-citation></ref><ref id="ref028"><label>[28]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gulbranson</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Hou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Bolin</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Ruotti</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Probasco</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Smuga-Otto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Howden</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Diol</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Propson</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>GO</given-names>
</string-name>, <string-name>
<surname>Antosiewicz-Bourget</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Teng</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</string-name>
(<year>2011</year>) <article-title>Chemically defined conditions for human iPSC derivation and culture</article-title>. <source>Nat Methods</source>
<volume>8</volume>, <fpage>424</fpage>&#x02013;<lpage>429</lpage>.<pub-id pub-id-type="pmid">21478862</pub-id></mixed-citation></ref><ref id="ref029"><label>[29]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Beers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gulbranson</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>George</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Siniscalchi</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>
(<year>2012</year>) <article-title>Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions</article-title>. <source>Nat Protoc</source>
<volume>7</volume>, <fpage>2029</fpage>&#x02013;<lpage>2040</lpage>.<pub-id pub-id-type="pmid">23099485</pub-id></mixed-citation></ref><ref id="ref030"><label>[30]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Reed</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</string-name>
(<year>2016</year>) <article-title>Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance</article-title>. <source>J Neurochem</source>
<volume>139</volume>(<issue>Suppl 1</issue>), <fpage>59</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">27090875</pub-id></mixed-citation></ref><ref id="ref031"><label>[31]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ferreira</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Massano</surname>
<given-names>J</given-names>
</string-name>
(<year>2017</year>) <article-title>An updated review of Parkinson&#x02019;s disease genetics and clinicopathological correlations</article-title>. <source>Acta Neurol Scand</source>
<volume>135</volume>, <fpage>273</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">27273099</pub-id></mixed-citation></ref><ref id="ref032"><label>[32]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Abeliovich</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schmitz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Farinas</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Choi-Lundberg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Castillo</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Shinsky</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Verdugo</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Armanini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ryan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hynes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Phillips</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rosenthal</surname>
<given-names>A</given-names>
</string-name>
(<year>2000</year>) <article-title>Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system</article-title>. <source>Neuron</source>
<volume>25</volume>, <fpage>239</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">10707987</pub-id></mixed-citation></ref><ref id="ref033"><label>[33]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yavich</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vepsalainen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jakala</surname>
<given-names>P</given-names>
</string-name>
(<year>2004</year>) <article-title>Role of alpha-synuclein in presynaptic dopamine recruitment</article-title>. <source>J Neurosci</source>
<volume>24</volume>, <fpage>11165</fpage>&#x02013;<lpage>11170</lpage>.<pub-id pub-id-type="pmid">15590933</pub-id></mixed-citation></ref><ref id="ref034"><label>[34]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Yavich</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jakala</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tanila</surname>
<given-names>H</given-names>
</string-name>
(<year>2006</year>) <article-title>Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice</article-title>. <source>J Neurochem</source>
<volume>99</volume>, <fpage>724</fpage>&#x02013;<lpage>732</lpage>.<pub-id pub-id-type="pmid">16824047</pub-id></mixed-citation></ref><ref id="ref035"><label>[35]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Frohman</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>AJ</given-names>
</string-name>
(<year>1996</year>) <article-title>Rho is only ARF the story. Phospholipid signalling</article-title>. <source>Curr Biol</source>
<volume>6</volume>, <fpage>945</fpage>&#x02013;<lpage>947</lpage>.<pub-id pub-id-type="pmid">8805317</pub-id></mixed-citation></ref><ref id="ref036"><label>[36]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Paik</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>CH</given-names>
</string-name>
(<year>2002</year>) <article-title>Structural and functional implications of C-terminal regions of alpha-synuclein</article-title>. <source>Biochemistry</source>
<volume>41</volume>, <fpage>13782</fpage>&#x02013;<lpage>13790</lpage>.<pub-id pub-id-type="pmid">12427041</pub-id></mixed-citation></ref><ref id="ref037"><label>[37]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Spillantini</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Jakes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Goedert</surname>
<given-names>M</given-names>
</string-name>
(<year>1997</year>) <article-title>Alpha-synuclein in Lewy bodies</article-title>. <source>Nature</source>
<volume>388</volume>, <fpage>839</fpage>&#x02013;<lpage>840</lpage>.<pub-id pub-id-type="pmid">9278044</pub-id></mixed-citation></ref><ref id="ref038"><label>[38]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Koprich</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Kalia</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Brotchie</surname>
<given-names>JM</given-names>
</string-name>
(<year>2017</year>) <article-title>Animal models of alpha-synucleinopathy for Parkinson disease drug development</article-title>. <source>Nat Rev Neurosci</source>
<volume>18</volume>, <fpage>515</fpage>&#x02013;<lpage>529</lpage>.<pub-id pub-id-type="pmid">28747776</pub-id></mixed-citation></ref><ref id="ref039"><label>[39]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Goedert</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jakes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Spillantini</surname>
<given-names>MG</given-names>
</string-name>
(<year>2017</year>) <article-title>The synucleinopathies: Twenty years on.S53-S</article-title>. <source>J Parkinsons Dis</source>
<volume>7</volume>, <fpage>71</fpage>.</mixed-citation></ref><ref id="ref040"><label>[40]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kruger</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Woitalla</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Graeber</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kosel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Przuntek</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Epplen</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Schols</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Riess</surname>
<given-names>O</given-names>
</string-name>
(<year>1998</year>) <article-title>Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson&#x02019;s disease</article-title>. <source>Nat Genet</source>
<volume>18</volume>, <fpage>106</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">9462735</pub-id></mixed-citation></ref><ref id="ref041"><label>[41]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kruger</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kuhn</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Leenders</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Sprengelmeyer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Woitalla</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Portman</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Maguire</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Veenma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Schroder</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Schols</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Epplen</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Riess</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Przuntek</surname>
<given-names>H</given-names>
</string-name>
(<year>2001</year>) <article-title>Familial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers</article-title>. <source>Neurology</source>
<volume>56</volume>, <fpage>1355</fpage>&#x02013;<lpage>1362</lpage>.<pub-id pub-id-type="pmid">11376188</pub-id></mixed-citation></ref><ref id="ref042"><label>[42]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Seidel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schols</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nuber</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Petrasch-Parwez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gierga</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Dickson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gai</surname>
<given-names>WP</given-names>
</string-name>, <string-name>
<surname>Bornemann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Riess</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Rami</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Den Dunnen</surname>
<given-names>WF</given-names>
</string-name>, <string-name>
<surname>Deller</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rub</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Kruger</surname>
<given-names>R</given-names>
</string-name>
(<year>2010</year>) <article-title>First appraisal of brain pathology owing to A30P mutant alpha-synuclein</article-title>. <source>Ann Neurol</source>
<volume>67</volume>, <fpage>684</fpage>&#x02013;<lpage>689</lpage>.<pub-id pub-id-type="pmid">20437567</pub-id></mixed-citation></ref><ref id="ref043"><label>[43]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Martikainen</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Paivarinta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hietala</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kaasinen</surname>
<given-names>V</given-names>
</string-name>
(<year>2015</year>) <article-title>Clinical and imaging findings in Parkinson disease associated with the A53E SNCA mutation</article-title>. <source>Neurol Genet</source>
<volume>1</volume>, <fpage>e27</fpage>.<pub-id pub-id-type="pmid">27066564</pub-id></mixed-citation></ref><ref id="ref044"><label>[44]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pasanen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Myllykangas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Siitonen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Raunio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kaakkola</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lyytinen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tienari</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Poyhonen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Paetau</surname>
<given-names>A</given-names>
</string-name>
(<year>2014</year>) <article-title>Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson&#x02019;s disease-type pathology</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>, <fpage>2180</fpage>
<fpage>e2181</fpage>&#x02013;<lpage>2185</lpage>.<pub-id pub-id-type="pmid">24746362</pub-id></mixed-citation></ref><ref id="ref045"><label>[45]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Polymeropoulos</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Lavedan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Leroy</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ide</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Dehejia</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dutra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pike</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Root</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stenroos</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Chandrasekharappa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Athanassiadou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Papapetropoulos</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Lazzarini</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Duvoisin</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>DiIorio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</string-name>
(<year>1997</year>) <article-title>Mutation in the alpha-synuclein gene identified in families with Parkinson&#x02019;s disease</article-title>. <source>Science</source>
<volume>276</volume>, <fpage>2045</fpage>&#x02013;<lpage>2047</lpage>.<pub-id pub-id-type="pmid">9197268</pub-id></mixed-citation></ref><ref id="ref046"><label>[46]</label><mixed-citation publication-type="journal">(<year>2015</year>) <article-title>Correction: Behoral phenotyping of Parkin-deficient mice: Looking for early preclinical features of Parkinson&#x02019;s disease</article-title>. <source>PLoS One</source>
<volume>10</volume>, <fpage>e0118526</fpage>.<pub-id pub-id-type="pmid">25742613</pub-id></mixed-citation></ref><ref id="ref047"><label>[47]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kiely</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Asi</surname>
<given-names>YT</given-names>
</string-name>, <string-name>
<surname>Kara</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Limousin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Proukakis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Quinn</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>JL</given-names>
</string-name>
(<year>2013</year>) <article-title>alpha-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson&#x02019;s disease and multiple system atrophy?</article-title>
<source>Acta Neuropathol</source>
<volume>125</volume>, <fpage>753</fpage>&#x02013;<lpage>769</lpage>.<pub-id pub-id-type="pmid">23404372</pub-id></mixed-citation></ref><ref id="ref048"><label>[48]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kiely</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Asi</surname>
<given-names>YT</given-names>
</string-name>, <string-name>
<surname>Kara</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Proukakis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schapira</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Lubbe</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Limousin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Lees</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Quinn</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Love</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Revesz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Holton</surname>
<given-names>JL</given-names>
</string-name>
(<year>2015</year>) <article-title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation</article-title>. <source>Mol Neurodegener</source>
<volume>10</volume>, <fpage>41</fpage>.<pub-id pub-id-type="pmid">26306801</pub-id></mixed-citation></ref><ref id="ref049"><label>[49]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Lesage</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Anheim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Letournel</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bousset</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Honore</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rozas</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pieri</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Madiona</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Durr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Melki</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Verny</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <collab>French Parkinson&#x02019;s Disease Genetics Study Group</collab>
(<year>2013</year>) <article-title>G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome</article-title>. <source>Ann Neurol</source>
<volume>73</volume>, <fpage>459</fpage>&#x02013;<lpage>471</lpage>.<pub-id pub-id-type="pmid">23526723</pub-id></mixed-citation></ref><ref id="ref050"><label>[50]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Appel-Cresswell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vilarino-Guell</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Encarnacion</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Weir</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Szu-Tu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Trinh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aasly</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rajput</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Jon Stoessl</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>MJ</given-names>
</string-name>
(<year>2013</year>) <article-title>Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson&#x02019;s disease</article-title>. <source>Mov Disord</source>
<volume>28</volume>, <fpage>811</fpage>&#x02013;<lpage>813</lpage>.<pub-id pub-id-type="pmid">23457019</pub-id></mixed-citation></ref><ref id="ref051"><label>[51]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Polymeropoulos</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Lavedan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Leroy</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ide</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Dehejia</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dutra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pike</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Root</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rubenstein</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Boyer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stenroos</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Chandrasekharappa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Athanassiadou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Papapetropoulos</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Lazzarini</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Duvoisin</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Di Iorio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</string-name>
(<year>1997</year>) <article-title>Mutation in the alpha-synuclein gene identified in families with Parkinson&#x02019;s disease</article-title>. <source>Science</source>
<volume>276</volume>, <fpage>2045</fpage>&#x02013;<lpage>2047</lpage>.<pub-id pub-id-type="pmid">9197268</pub-id></mixed-citation></ref><ref id="ref052"><label>[52]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hague</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kachergus</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hulihan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peuralinna</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dutra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nussbaum</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Crawley</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hanson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maraganore</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Muenter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baptista</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Blancato</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gwinn-Hardy</surname>
<given-names>K</given-names>
</string-name>
(<year>2003</year>) <article-title>alpha-Synuclein locus triplication causes Parkinson&#x02019;s disease</article-title>. <source>Science</source>
<volume>302</volume>, <fpage>841</fpage>.<pub-id pub-id-type="pmid">14593171</pub-id></mixed-citation></ref><ref id="ref053"><label>[53]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Devine</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Gwinn</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>
(<year>2011</year>) <article-title>Parkinson&#x02019;s disease and alpha-synuclein expression</article-title>. <source>Mov Disord</source>
<volume>26</volume>, <fpage>2160</fpage>&#x02013;<lpage>2168</lpage>.<pub-id pub-id-type="pmid">21887711</pub-id></mixed-citation></ref><ref id="ref054"><label>[54]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Devine</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Ryten</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vodicka</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Burdon</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Houlden</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cavaleri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nagano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Drummond</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Taanman</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Schapira</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Gwinn</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Kunath</surname>
<given-names>T</given-names>
</string-name>
(<year>2011</year>) <article-title>Parkinson&#x02019;s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus</article-title>. <source>Nat Commun</source>
<volume>2</volume>, <fpage>440</fpage>.<pub-id pub-id-type="pmid">21863007</pub-id></mixed-citation></ref><ref id="ref055"><label>[55]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Byers</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cord</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fenno</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Deisseroth</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Langston</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Pera</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>TD</given-names>
</string-name>
(<year>2011</year>) <article-title>SNCA triplication Parkinson&#x02019;s patient&#x02019;s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress</article-title>. <source>PLoS One</source>
<volume>6</volume>, <fpage>e26159</fpage>.<pub-id pub-id-type="pmid">22110584</pub-id></mixed-citation></ref><ref id="ref056"><label>[56]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Flierl</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Oliveira</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Falomir-Lockhart</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Mak</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Hesley</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Soldner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Arndt-Jovin</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Langston</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Jovin</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>
(<year>2014</year>) <article-title>Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e112413</fpage>.<pub-id pub-id-type="pmid">25390032</pub-id></mixed-citation></ref><ref id="ref057"><label>[57]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Oliveira</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Falomir-Lockhart</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Botelho</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Wales</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Gerhardt</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Taschenberger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Outeiro</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Lingor</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Arndt-Jovin</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Jovin</surname>
<given-names>TM</given-names>
</string-name>
(<year>2015</year>) <article-title>Elevated alpha-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson&#x02019;s patient-derived induced pluripotent stem cells</article-title>. <source>Cell Death Dis</source>
<volume>6</volume>, <fpage>e1994</fpage>.<pub-id pub-id-type="pmid">26610207</pub-id></mixed-citation></ref><ref id="ref058"><label>[58]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Soldner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Laganiere</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Hockemeyer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Alagappan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Khurana</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Golbe</surname>
<given-names>LI</given-names>
</string-name>, <string-name>
<surname>Myers</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Guschin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Fong</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Vu</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Urnov</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Rebar</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Gregory</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>
(<year>2011</year>) <article-title>Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations</article-title>. <source>Cell</source>
<volume>146</volume>, <fpage>318</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">21757228</pub-id></mixed-citation></ref><ref id="ref059"><label>[59]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chung</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Khurana</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Auluck</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Tardiff</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Mazzulli</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Soldner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Baru</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Freyzon</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mungenast</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Muffat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mitalipova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pluth</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Jui</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lippard</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Buchwald</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</string-name>
(<year>2013</year>) <article-title>Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons</article-title>. <source>Science</source>
<volume>342</volume>, <fpage>983</fpage>&#x02013;<lpage>987</lpage>.<pub-id pub-id-type="pmid">24158904</pub-id></mixed-citation></ref><ref id="ref060"><label>[60]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ryan</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Dolatabadi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Akhtar</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Soldner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sunico</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Nagar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Talantova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nutter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Molokanova</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Masliah</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Yates</surname>
<given-names>JR</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Andreyev</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ambasudhan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lipton</surname>
<given-names>SA</given-names>
</string-name>
(<year>2013</year>) <article-title>Isogenic human iPSC Parkinson&#x02019;s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription</article-title>. <source>Cell</source>
<volume>155</volume>, <fpage>1351</fpage>&#x02013;<lpage>1364</lpage>.<pub-id pub-id-type="pmid">24290359</pub-id></mixed-citation></ref><ref id="ref061"><label>[61]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Soldner</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Stelzer</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shivalila</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Abraham</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Latourelle</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Barrasa</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Goldmann</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Myers</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>
(<year>2016</year>) <article-title>Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression</article-title>. <source>Nature</source>
<volume>533</volume>, <fpage>95</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">27096366</pub-id></mixed-citation></ref><ref id="ref062"><label>[62]</label><mixed-citation publication-type="journal">
<string-name>
<surname>MacLeod</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dowman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hammond</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Leete</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abeliovich</surname>
<given-names>A</given-names>
</string-name>
(<year>2006</year>) <article-title>The familial Parkinsonism gene LRRK2 regulates neurite process morphology</article-title>. <source>Neuron</source>
<volume>52</volume>, <fpage>587</fpage>&#x02013;<lpage>593</lpage>.<pub-id pub-id-type="pmid">17114044</pub-id></mixed-citation></ref><ref id="ref063"><label>[63]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Parisiadou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>XL</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>CX</given-names>
</string-name>, <string-name>
<surname>Lobbestael</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Baekelandt</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Taymans</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>H</given-names>
</string-name>
(<year>2009</year>) <article-title>Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis</article-title>. <source>J Neurosci</source>
<volume>29</volume>, <fpage>13971</fpage>&#x02013;<lpage>13980</lpage>.<pub-id pub-id-type="pmid">19890007</pub-id></mixed-citation></ref><ref id="ref064"><label>[64]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gillardon</surname>
<given-names>F</given-names>
</string-name>
(<year>2009</year>) <article-title>Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability&#x02013;a point of convergence in parkinsonian neurodegeneration?</article-title>
<source>J Neurochem</source>
<volume>110</volume>, <fpage>1514</fpage>&#x02013;<lpage>1522</lpage>.<pub-id pub-id-type="pmid">19545277</pub-id></mixed-citation></ref><ref id="ref065"><label>[65]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Plowey</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Cherra</surname>
<given-names>SJ</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>CT</given-names>
</string-name>
(<year>2008</year>) <article-title>Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells</article-title>. <source>J Neurochem</source>
<volume>105</volume>, <fpage>1048</fpage>&#x02013;<lpage>1056</lpage>.<pub-id pub-id-type="pmid">18182054</pub-id></mixed-citation></ref><ref id="ref066"><label>[66]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Shin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Heo</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Yun</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hatano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Seol</surname>
<given-names>W</given-names>
</string-name>
(<year>2008</year>) <article-title>LRRK2 regulates synaptic vesicle endocytosis</article-title>. <source>Exp Cell Res</source>
<volume>314</volume>, <fpage>2055</fpage>&#x02013;<lpage>2065</lpage>.<pub-id pub-id-type="pmid">18445495</pub-id></mixed-citation></ref><ref id="ref067"><label>[67]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gomez-Suaga</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rivero-Rios</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fdez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Blanca Ramirez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ferrer</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Aiastui</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lopez De Munain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hilfiker</surname>
<given-names>S</given-names>
</string-name>
(<year>2014</year>) <article-title>LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity</article-title>. <source>Hum Mol Genet</source>
<volume>23</volume>, <fpage>6779</fpage>&#x02013;<lpage>6796</lpage>.<pub-id pub-id-type="pmid">25080504</pub-id></mixed-citation></ref><ref id="ref068"><label>[68]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Roosen</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>
(<year>2016</year>) <article-title>LRRK2 at the interface of autophagosomes, endosomes and lysosomes</article-title>. <source>Mol Neurodegener</source>
<volume>11</volume>, <fpage>73</fpage>.<pub-id pub-id-type="pmid">27927216</pub-id></mixed-citation></ref><ref id="ref069"><label>[69]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Esteves</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Cardoso</surname>
<given-names>SM</given-names>
</string-name>
(<year>2017</year>) <article-title>LRRK2 at the crossroad between autophagy and microtubule trafficking: Insights into Parkinson&#x02019;s disease</article-title>. <source>Neuroscientist</source>
<volume>23</volume>, <fpage>16</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">26740081</pub-id></mixed-citation></ref><ref id="ref070"><label>[70]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Clark</surname>
<given-names>LN</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Karlins</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Mejia-Santana</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Louis</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Cote</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Andrews</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fahn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Waters</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ford</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Frucht</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ottman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Marder</surname>
<given-names>K</given-names>
</string-name>
(<year>2006</year>) <article-title>Frequency of LRRK2 mutations in early- and late-onset Parkinson disease</article-title>. <source>Neurology</source>
<volume>67</volume>, <fpage>1786</fpage>&#x02013;<lpage>1791</lpage>.<pub-id pub-id-type="pmid">17050822</pub-id></mixed-citation></ref><ref id="ref071"><label>[71]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Marder</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Alcalay</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Mejia-Santana</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>MX</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Raymond</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mirelman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Saunders-Pullman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ozelius</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Orr-Urtreger</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Giladi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bressman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Consortium</surname>
<given-names>LAJ</given-names>
</string-name>
(<year>2015</year>) <article-title>Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium</article-title>. <source>Neurology</source>
<volume>85</volume>, <fpage>89</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">26062626</pub-id></mixed-citation></ref><ref id="ref072"><label>[72]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bardien</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lesage</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Carr</surname>
<given-names>J</given-names>
</string-name>
(<year>2011</year>) <article-title>Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson&#x02019;s disease</article-title>. <source>Parkinsonism Relat Disord</source>
<volume>17</volume>, <fpage>501</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">21641266</pub-id></mixed-citation></ref><ref id="ref073"><label>[73]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Nguyen</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Byers</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cord</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Byrne</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gujar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Dolmetsch</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Langston</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Pera</surname>
<given-names>RR</given-names>
</string-name>
(<year>2011</year>) <article-title>LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress</article-title>. <source>Cell Stem Cell</source>
<volume>8</volume>, <fpage>267</fpage>&#x02013;<lpage>280</lpage>.<pub-id pub-id-type="pmid">21362567</pub-id></mixed-citation></ref><ref id="ref074"><label>[74]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Reinhardt</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Burbulla</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Schondorf</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Glatza</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hoing</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hargus</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Heck</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Dhingra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brockmann</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kluba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Maisel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kruger</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tsytsyura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Thiel</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Psathaki</surname>
<given-names>OE</given-names>
</string-name>, <string-name>
<surname>Klingauf</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuhlmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Klewin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Scholer</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Sterneckert</surname>
<given-names>J</given-names>
</string-name>
(<year>2013</year>) <article-title>Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression</article-title>. <source>Cell Stem Cell</source>
<volume>12</volume>, <fpage>354</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">23472874</pub-id></mixed-citation></ref><ref id="ref075"><label>[75]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Skibinski</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cookson</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Finkbeiner</surname>
<given-names>S</given-names>
</string-name>
(<year>2014</year>) <article-title>Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies</article-title>. <source>J Neurosci</source>
<volume>34</volume>, <fpage>418</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">24403142</pub-id></mixed-citation></ref><ref id="ref076"><label>[76]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sanchez-Danes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Richaud-Patin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Carballo-Carbajal</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Jimenez-Delgado</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Caig</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mora</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Di Guglielmo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ezquerra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Giralt</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Canals</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Memo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alberch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lopez-Barneo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vila</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cuervo</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Tolosa</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Consiglio</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Raya</surname>
<given-names>A</given-names>
</string-name>
(<year>2012</year>) <article-title>Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson&#x02019;s disease</article-title>. <source>EMBO Mol Med</source>
<volume>4</volume>, <fpage>380</fpage>&#x02013;<lpage>395</lpage>.<pub-id pub-id-type="pmid">22407749</pub-id></mixed-citation></ref><ref id="ref077"><label>[77]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sanders</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Laganiere</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mak</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Vu</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Paschon</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Vangipuram</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sundararajan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Urnov</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Langston</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Gregory</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Greenamyre</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Isacson</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>
(<year>2014</year>) <article-title>LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson&#x02019;s disease patients: Reversal by gene correction</article-title>. <source>Neurobiol Dis</source>
<volume>62</volume>, <fpage>381</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">24148854</pub-id></mixed-citation></ref><ref id="ref078"><label>[78]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hsieh</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Shaltouki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Bettencourt da Cruz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Burbulla</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>St Lawrence</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Schule</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>
(<year>2016</year>) <article-title>Functional impairment in miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson&#x02019;s disease</article-title>. <source>Cell Stem Cell</source>
<volume>19</volume>, <fpage>709</fpage>&#x02013;<lpage>724</lpage>.<pub-id pub-id-type="pmid">27618216</pub-id></mixed-citation></ref><ref id="ref079"><label>[79]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kitada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Asakawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Matsumine</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamamura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Minoshima</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yokochi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>N</given-names>
</string-name>
(<year>1998</year>) <article-title>Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism</article-title>. <source>Nature</source>
<volume>392</volume>, <fpage>605</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">9560156</pub-id></mixed-citation></ref><ref id="ref080"><label>[80]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Shimura</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kubo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Asakawa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Minoshima</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Iwai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Chiba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>
(<year>2000</year>) <article-title>Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.302-305.</article-title>. <source>Nat Genet</source>
<volume>25</volume>.</mixed-citation></ref><ref id="ref081"><label>[81]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Panicker</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>TM</given-names>
</string-name>
(<year>2017</year>) <article-title>Activation mechanisms of the E3 ubiquitin ligase parkin</article-title>. <source>Biochem J</source>
<volume>474</volume>, <fpage>3075</fpage>&#x02013;<lpage>3086</lpage>.<pub-id pub-id-type="pmid">28860335</pub-id></mixed-citation></ref><ref id="ref082"><label>[82]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>
(<year>2010</year>) <article-title>Genetic analysis of pathways to Parkinson disease</article-title>. <source>Neuron</source>
<volume>68</volume>, <fpage>201</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">20955928</pub-id></mixed-citation></ref><ref id="ref083"><label>[83]</label><mixed-citation publication-type="journal">
<string-name>
<surname>L&#x000fc;cking</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>Durr</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bonifati</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vaughan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>De Michele</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Harhangi</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Meco</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Denefle</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>NW</given-names>
</string-name>, <string-name>
<surname>Agid</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <collab>French Parkinson&#x02019;s Disease Genetics Study G, European Consortium on Genetic Susceptibility in Parkinson&#x02019;s Disease</collab>
(<year>2000</year>) <article-title>Association between early-onset Parkinson&#x02019;s disease and mutations in the parkin gene</article-title>. <source>N Engl J Med</source>
<volume>342</volume>, <fpage>1560</fpage>&#x02013;<lpage>1567</lpage>.<pub-id pub-id-type="pmid">10824074</pub-id></mixed-citation></ref><ref id="ref084"><label>[84]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Goldberg</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Fleming</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Palacino</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Cepeda</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lam</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Bhatnagar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meloni</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ackerson</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Klapstein</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Gajendiran</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roth</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Chesselet</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Maidment</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>J</given-names>
</string-name>
(<year>2003</year>) <article-title>Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons</article-title>. <source>J Biol Chem</source>
<volume>278</volume>, <fpage>43628</fpage>&#x02013;<lpage>43635</lpage>.<pub-id pub-id-type="pmid">12930822</pub-id></mixed-citation></ref><ref id="ref085"><label>[85]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Perez</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Palmiter</surname>
<given-names>RD</given-names>
</string-name>
(<year>2005</year>) <article-title>Parkin-deficient mice are not a robust model of parkinsonism</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>, <fpage>2174</fpage>&#x02013;<lpage>2179</lpage>.<pub-id pub-id-type="pmid">15684050</pub-id></mixed-citation></ref><ref id="ref086"><label>[86]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Dave</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>De Silva</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sheth</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Ramboz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Beck</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Quang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Switzer</surname>
<given-names>RC</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Ahmad</surname>
<given-names>SO</given-names>
</string-name>, <string-name>
<surname>Sunkin</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>McCoy</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Gamber</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Goldberg</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Benkovic</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Haupt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baptista</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Fiske</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Sherer</surname>
<given-names>TB</given-names>
</string-name>, <string-name>
<surname>Frasier</surname>
<given-names>MA</given-names>
</string-name>
(<year>2014</year>) <article-title>Phenotypic characterization of recessive gene knockout rat models of Parkinson&#x02019;s disease</article-title>. <source>Neurobiol Dis</source>
<volume>70</volume>, <fpage>190</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">24969022</pub-id></mixed-citation></ref><ref id="ref087"><label>[87]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2004</year>) <article-title>Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis</article-title>. <source>Hum Mol Genet</source>
<volume>13</volume>, <fpage>1745</fpage>&#x02013;<lpage>1754</lpage>.<pub-id pub-id-type="pmid">15198987</pub-id></mixed-citation></ref><ref id="ref088"><label>[88]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2006</year>) <article-title>Parkin suppresses the expression of monoamine oxidases</article-title>. <source>J Biol Chem</source>
<volume>281</volume>, <fpage>8591</fpage>&#x02013;<lpage>8599</lpage>.<pub-id pub-id-type="pmid">16455660</pub-id></mixed-citation></ref><ref id="ref089"><label>[89]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nakaso</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2011</year>) <article-title>Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases</article-title>. <source>Hum Mol Genet</source>
<volume>20</volume>, <fpage>1074</fpage>&#x02013;<lpage>1083</lpage>.<pub-id pub-id-type="pmid">21177257</pub-id></mixed-citation></ref><ref id="ref090"><label>[90]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Schreiber</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Emter</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hock</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Knutti</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Cardenas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Podvinec</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Oakeley</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Kralli</surname>
<given-names>A</given-names>
</string-name>
(<year>2004</year>) <article-title>The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>, <fpage>6472</fpage>&#x02013;<lpage>6477</lpage>.<pub-id pub-id-type="pmid">15087503</pub-id></mixed-citation></ref><ref id="ref091"><label>[91]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yuen</surname>
<given-names>EY</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ghaedi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Azabdaftari</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nakaso</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2012</year>) <article-title>Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells</article-title>. <source>Nat Commun</source>
<volume>3</volume>, <fpage>668</fpage>.<pub-id pub-id-type="pmid">22314364</pub-id></mixed-citation></ref><ref id="ref092"><label>[92]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Imaizumi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Akamatsu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kuzumaki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hayakawa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nihira</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ohyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takanashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Funayama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hirayama</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Soga</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hishiki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Suematsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yagi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kosakai</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shouji</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakanishi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Amagai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mochizuki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Okano</surname>
<given-names>H</given-names>
</string-name>
(<year>2012</year>) <article-title>Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue</article-title>. <source>Mol Brain</source>
<volume>5</volume>, <fpage>35</fpage>.<pub-id pub-id-type="pmid">23039195</pub-id></mixed-citation></ref><ref id="ref093"><label>[93]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chung</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Kishinevsky</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mazzulli</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Graziotto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mrejeru</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mosharov</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Puspita</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Valiulahi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Milner</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Taldone</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>JW</given-names>
</string-name>
(<year>2016</year>) <article-title>Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and alpha-synuclein accumulation</article-title>. <source>Stem Cell Reports</source>
<volume>7</volume>, <fpage>664</fpage>&#x02013;<lpage>677</lpage>.<pub-id pub-id-type="pmid">27641647</pub-id></mixed-citation></ref><ref id="ref094"><label>[94]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2017</year>) <article-title>Dopamine induces oscillatory activities in human midbrain neurons with parkin mutations</article-title>. <source>Cell Rep</source>
<volume>19</volume>, <fpage>1033</fpage>&#x02013;<lpage>1044</lpage>.<pub-id pub-id-type="pmid">28467897</pub-id></mixed-citation></ref><ref id="ref095"><label>[95]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Brittain</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>P</given-names>
</string-name>
(<year>2014</year>) <article-title>Oscillations and the basal ganglia: Motor control and beyond</article-title>. <source>Neuroimage</source>
<volume>85</volume>(<issue>Pt 2</issue>), <fpage>637</fpage>&#x02013;<lpage>647</lpage>.<pub-id pub-id-type="pmid">23711535</pub-id></mixed-citation></ref><ref id="ref096"><label>[96]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Janoschka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2015</year>) <article-title>Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons</article-title>. <source>Stem Cells</source>
<volume>33</volume>, <fpage>68</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">25332110</pub-id></mixed-citation></ref><ref id="ref097"><label>[97]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Cartelli</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Amadeo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Calogero</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Casagrande</surname>
<given-names>FVM</given-names>
</string-name>, <string-name>
<surname>De Gregorio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gioria</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kuzumaki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Costa</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sassone</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ciammola</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hattori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Okano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Goldwurm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Roybon</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pezzoli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cappelletti</surname>
<given-names>G</given-names>
</string-name>
(<year>2018</year>) <article-title>Parkin absence accelerates microtubule aging in dopaminergic neurons</article-title>. <source>Neurobiol Aging</source>
<volume>61</volume>, <fpage>66</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">29040870</pub-id></mixed-citation></ref><ref id="ref098"><label>[98]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Farrer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lincoln</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Forno</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gwinn-Hardy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Petrucelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hussey</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Singleton</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tanner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Langston</surname>
<given-names>JW</given-names>
</string-name>
(<year>2001</year>) <article-title>Lewy bodies and parkinsonism in families with parkin mutations</article-title>. <source>Ann Neurol</source>
<volume>50</volume>, <fpage>293</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">11558785</pub-id></mixed-citation></ref><ref id="ref099"><label>[99]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Shaltouki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sivapatham</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pei</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gerencser</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Momcilovic</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>
<given-names>X</given-names>
</string-name>
(<year>2015</year>) <article-title>Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines</article-title>. <source>Stem Cell Reports</source>
<volume>4</volume>, <fpage>847</fpage>&#x02013;<lpage>859</lpage>.<pub-id pub-id-type="pmid">25843045</pub-id></mixed-citation></ref><ref id="ref100"><label>[100]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Narendra</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Suen</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Youle</surname>
<given-names>RJ</given-names>
</string-name>
(<year>2008</year>) <article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title>. <source>J Cell Biol</source>
<volume>183</volume>, <fpage>795</fpage>&#x02013;<lpage>803</lpage>.<pub-id pub-id-type="pmid">19029340</pub-id></mixed-citation></ref><ref id="ref101"><label>[101]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pickrell</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Youle</surname>
<given-names>RJ</given-names>
</string-name>
(<year>2015</year>) <article-title>The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson&#x02019;s disease</article-title>. <source>Neuron</source>
<volume>85</volume>, <fpage>257</fpage>&#x02013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">25611507</pub-id></mixed-citation></ref><ref id="ref102"><label>[102]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Scarffe</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>TM</given-names>
</string-name>
(<year>2014</year>) <article-title>Parkin and PINK1: Much more than mitophagy</article-title>. <source>Trends Neurosci</source>
<volume>37</volume>, <fpage>315</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">24735649</pub-id></mixed-citation></ref><ref id="ref103"><label>[103]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Grenier</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McLelland</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Fon</surname>
<given-names>EA</given-names>
</string-name>
(<year>2013</year>) <article-title>Parkin- and PINK1-dependent mitophagy in neurons: Will the real pathway please stand up?</article-title>
<source>Front Neurol</source>
<volume>4</volume>, <fpage>100</fpage>.<pub-id pub-id-type="pmid">23882257</pub-id></mixed-citation></ref><ref id="ref104"><label>[104]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sterky</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wibom</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Olson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Larsson</surname>
<given-names>NG</given-names>
</string-name>
(<year>2011</year>) <article-title>Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>, <fpage>12937</fpage>&#x02013;<lpage>12942</lpage>.<pub-id pub-id-type="pmid">21768369</pub-id></mixed-citation></ref><ref id="ref105"><label>[105]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kageyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Roda</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fukaya</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wakabayashi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wakabayashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kensler</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Iijima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sesaki</surname>
<given-names>H</given-names>
</string-name>
(<year>2012</year>) <article-title>Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage</article-title>. <source>J Cell Biol</source>
<volume>197</volume>, <fpage>535</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">22564413</pub-id></mixed-citation></ref><ref id="ref106"><label>[106]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rakovic</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shurkewitsch</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Seibler</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Grunewald</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zanon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hagenah</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>C</given-names>
</string-name>
(<year>2013</year>) <article-title>Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: Study in human primary fibroblasts and induced pluripotent stem cell-derived neurons</article-title>. <source>J Biol Chem</source>
<volume>288</volume>, <fpage>2223</fpage>&#x02013;<lpage>2237</lpage>.<pub-id pub-id-type="pmid">23212910</pub-id></mixed-citation></ref><ref id="ref107"><label>[107]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Greene</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Grenier</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Aguileta</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Muise</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Farazifard</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Haque</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>McBride</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Fon</surname>
<given-names>EA</given-names>
</string-name>
(<year>2012</year>) <article-title>Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment</article-title>. <source>EMBO Rep</source>
<volume>13</volume>, <fpage>378</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">22354088</pub-id></mixed-citation></ref><ref id="ref108"><label>[108]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Seibler</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Graziotto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Simunovic</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>
(<year>2011</year>) <article-title>Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells</article-title>. <source>J Neurosci</source>
<volume>31</volume>, <fpage>5970</fpage>&#x02013;<lpage>5976</lpage>.<pub-id pub-id-type="pmid">21508222</pub-id></mixed-citation></ref><ref id="ref109"><label>[109]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Morais</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Haddad</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Craessaerts</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>De Bock</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Swerts</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vilain</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aerts</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Overbergh</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Grunewald</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Seibler</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gevaert</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Verstreken</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>De Strooper</surname>
<given-names>B</given-names>
</string-name>
(<year>2014</year>) <article-title>PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling</article-title>. <source>Science</source>
<volume>344</volume>, <fpage>203</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">24652937</pub-id></mixed-citation></ref><ref id="ref110"><label>[110]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Cooper</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Andrabi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Guardia-Laguarta</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Graziotto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sundberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McLean</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Carrillo-Reid</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Osborn</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hargus</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Deleidi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lawson</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bogetofte</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Perez-Torres</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Moskowitz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mazzulli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Volpicelli-Daley</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Romero</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Uitti</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Opala</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Scarffe</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Marder</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</string-name>, <string-name>
<surname>Przedborski</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Isacson</surname>
<given-names>O</given-names>
</string-name>
(<year>2012</year>) <article-title>Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson&#x02019;s disease</article-title>. <source>Sci Transl Med</source>
<volume>4</volume>, <fpage>141ra190</fpage>.</mixed-citation></ref><ref id="ref111"><label>[111]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Azkona</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lopez de Maturana</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Del Rio</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Sousa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Vazquez</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zubiarrain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jimenez-Blasco</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bolanos</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Morales</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Auburger</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Arbelo</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Sanchez-Pernaute</surname>
<given-names>R</given-names>
</string-name>
(<year>2018</year>) <article-title>LRRK2 expression is deregulated in fibroblasts and neurons from Parkinson patients with mutations in PINK1</article-title>. <source>Mol Neurobiol</source>
<volume>55</volume>, <fpage>506</fpage>&#x02013;<lpage>516</lpage>.<pub-id pub-id-type="pmid">27975167</pub-id></mixed-citation></ref><ref id="ref112"><label>[112]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bonifati</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rizzu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>van Baren</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Schaap</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Breedveld</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Krieger</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Dekker</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Squitieri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ibanez</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Joosse</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>van Dongen</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Vanacore</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>van Swieten</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Brice</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Meco</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van Duijn</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Heutink</surname>
<given-names>P</given-names>
</string-name>
(<year>2003</year>) <article-title>Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism</article-title>. <source>Science</source>
<volume>299</volume>, <fpage>256</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">12446870</pub-id></mixed-citation></ref><ref id="ref113"><label>[113]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wilson</surname>
<given-names>MA</given-names>
</string-name>
(<year>2011</year>) <article-title>The role of cysteine oxidation in DJ-1 function and dysfunction</article-title>. <source>Antioxid Redox Signal</source>
<volume>15</volume>, <fpage>111</fpage>&#x02013;<lpage>122</lpage>.<pub-id pub-id-type="pmid">20812780</pub-id></mixed-citation></ref><ref id="ref114"><label>[114]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Burbulla</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Mazzulli</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Zampese</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Santos</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Blanz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Obermaier</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Strojny</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Savas</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Kiskinis</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhuang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Kruger</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>
(<year>2017</year>) <article-title>Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson&#x02019;s disease</article-title>. <source>Science</source>
<volume>357</volume>, <fpage>1255</fpage>&#x02013;<lpage>1261</lpage>.<pub-id pub-id-type="pmid">28882997</pub-id></mixed-citation></ref><ref id="ref115"><label>[115]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sidransky</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>G</given-names>
</string-name>
(<year>2012</year>) <article-title>The link between the GBA gene and parkinsonism</article-title>. <source>Lancet Neurol</source>
<volume>11</volume>, <fpage>986</fpage>&#x02013;<lpage>998</lpage>.<pub-id pub-id-type="pmid">23079555</pub-id></mixed-citation></ref><ref id="ref116"><label>[116]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Schondorf</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Aureli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>McAllister</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Hindley</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Mayer</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sardi</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Valsecchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hoffmann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Hedrich</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shihabuddin</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pruszak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gygi</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Sonnino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gasser</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deleidi</surname>
<given-names>M</given-names>
</string-name>
(<year>2014</year>) <article-title>iPSC-derived neurons from GBA1-associated Parkinson&#x02019;s disease patients show autophagic defects and impaired calcium homeostasis</article-title>. <source>Nat Commun</source>
<volume>5</volume>, <fpage>4028</fpage>.<pub-id pub-id-type="pmid">24905578</pub-id></mixed-citation></ref><ref id="ref117"><label>[117]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Woodard</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Campos</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Nirenberg</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Nestor</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Zimmer</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mosharov</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Paull</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Schadt</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Sardi</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Rubin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eggan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brock</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lipnick</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Noggle</surname>
<given-names>SA</given-names>
</string-name>
(<year>2014</year>) <article-title>iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson&#x02019;s disease</article-title>. <source>Cell Rep</source>
<volume>9</volume>, <fpage>1173</fpage>&#x02013;<lpage>1182</lpage>.<pub-id pub-id-type="pmid">25456120</pub-id></mixed-citation></ref><ref id="ref118"><label>[118]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Iovino</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Agathou</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gonzalez-Rueda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Del Castillo Velasco-Herrera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Borroni</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Alberici</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>O&#x02019;Dowd</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Geti</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gaffney</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Vallier</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Paulsen</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Karadottir</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Spillantini</surname>
<given-names>MG</given-names>
</string-name>
(<year>2015</year>) <article-title>Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations</article-title>. <source>Brain</source>
<volume>138</volume>, <fpage>3345</fpage>&#x02013;<lpage>3359</lpage>.<pub-id pub-id-type="pmid">26220942</pub-id></mixed-citation></ref><ref id="ref119"><label>[119]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Fong</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Knoferle</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Balestra</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ring</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Karydas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kshirsagar</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Boxer</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Kosik</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>
(<year>2013</year>) <article-title>Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells</article-title>. <source>Stem Cell Reports</source>
<volume>1</volume>, <fpage>226</fpage>&#x02013;<lpage>234</lpage>.<pub-id pub-id-type="pmid">24319659</pub-id></mixed-citation></ref><ref id="ref120"><label>[120]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>
(<year>2015</year>) <article-title>Neuroinflammation in Parkinson&#x02019;s disease and its potential as therapeutic target</article-title>. <source>Transl Neurodegener</source>
<volume>4</volume>, <fpage>19</fpage>.<pub-id pub-id-type="pmid">26464797</pub-id></mixed-citation></ref><ref id="ref121"><label>[121]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Mogi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Riederer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Narabayashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fujita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nagatsu</surname>
<given-names>T</given-names>
</string-name>
(<year>1994</year>) <article-title>Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients</article-title>. <source>Neurosci Lett</source>
<volume>165</volume>, <fpage>208</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">8015728</pub-id></mixed-citation></ref><ref id="ref122"><label>[122]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Vila</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jackson-Lewis</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Guegan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Teismann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Tieu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Przedborski</surname>
<given-names>S</given-names>
</string-name>
(<year>2001</year>) <article-title>The role of glial cells in Parkinson&#x02019;s disease</article-title>. <source>Curr Opin Neurol</source>
<volume>14</volume>, <fpage>483</fpage>&#x02013;<lpage>489</lpage>.<pub-id pub-id-type="pmid">11470965</pub-id></mixed-citation></ref><ref id="ref123"><label>[123]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Mena</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Garcia de Yebenes</surname>
<given-names>J</given-names>
</string-name>
(<year>2008</year>) <article-title>Glial cells as players in parkinsonism: The &#x0201c;good,&#x0201d; the &#x0201c;bad,&#x0201d; and the &#x0201c;mysterious&#x0201d; glia</article-title>. <source>Neuroscientist</source>
<volume>14</volume>, <fpage>544</fpage>&#x02013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">19029058</pub-id></mixed-citation></ref><ref id="ref124"><label>[124]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kordower</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Emborg</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Bloch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Leventhal</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>McBride</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>EY</given-names>
</string-name>, <string-name>
<surname>Palfi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Roitberg</surname>
<given-names>BZ</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>Holden</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Pyzalski</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Carvey</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Trono</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hantraye</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Deglon</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Aebischer</surname>
<given-names>P</given-names>
</string-name>
(<year>2000</year>) <article-title>Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson&#x02019;s disease</article-title>. <source>Science</source>
<volume>290</volume>, <fpage>767</fpage>&#x02013;<lpage>773</lpage>.<pub-id pub-id-type="pmid">11052933</pub-id></mixed-citation></ref><ref id="ref125"><label>[125]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gash</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ovadia</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cass</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Simmerman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Russell</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lapchak</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hoffer</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Gerhardt</surname>
<given-names>GA</given-names>
</string-name>
(<year>1996</year>) <article-title>Functional recovery in parkinsonian monkeys treated with GDNF</article-title>. <source>Nature</source>
<volume>380</volume>, <fpage>252</fpage>&#x02013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">8637574</pub-id></mixed-citation></ref><ref id="ref126"><label>[126]</label><mixed-citation publication-type="journal">
<string-name>
<surname>d&#x02019;Anglemont de Tassigny</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Pascual</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lopez-Barneo</surname>
<given-names>J</given-names>
</string-name>
(<year>2015</year>) <article-title>GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson&#x02019;s disease</article-title>. <source>Front Neuroanat</source>
<volume>9</volume>, <fpage>10</fpage>.<pub-id pub-id-type="pmid">25762899</pub-id></mixed-citation></ref><ref id="ref127"><label>[127]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Su</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Maguire-Zeiss</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Giuliano</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Prifti</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Venkatesh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Federoff</surname>
<given-names>HJ</given-names>
</string-name>
(<year>2008</year>) <article-title>Synuclein activates microglia in a model of Parkinson&#x02019;s disease</article-title>. <source>Neurobiol Aging</source>
<volume>29</volume>, <fpage>1690</fpage>&#x02013;<lpage>1701</lpage>.<pub-id pub-id-type="pmid">17537546</pub-id></mixed-citation></ref><ref id="ref128"><label>[128]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gillardon</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Draheim</surname>
<given-names>H</given-names>
</string-name>
(<year>2012</year>) <article-title>Parkinson&#x02019;s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity</article-title>. <source>Neuroscience</source>
<volume>208</volume>, <fpage>41</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">22342962</pub-id></mixed-citation></ref><ref id="ref129"><label>[129]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Wernig</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Duncan</surname>
<given-names>ID</given-names>
</string-name>, <string-name>
<surname>Brustle</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>JA</given-names>
</string-name>
(<year>2001</year>) <article-title>In vitro differentiation of transplantable neural precursors from human embryonic stem cells</article-title>. <source>Nat Biotechnol</source>
<volume>19</volume>, <fpage>1129</fpage>&#x02013;<lpage>1133</lpage>.<pub-id pub-id-type="pmid">11731781</pub-id></mixed-citation></ref><ref id="ref130"><label>[130]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Chandrasekaran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Avci</surname>
<given-names>HX</given-names>
</string-name>, <string-name>
<surname>Leist</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kobolak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dinnyes</surname>
<given-names>A</given-names>
</string-name>
(<year>2016</year>) <article-title>Astrocyte differentiation of human pluripotent stem cells: New tools for neurological disorder research</article-title>. <source>Front Cell Neurosci</source>
<volume>10</volume>, <fpage>215</fpage>.<pub-id pub-id-type="pmid">27725795</pub-id></mixed-citation></ref><ref id="ref131"><label>[131]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Muffat</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mitalipova</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Omer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Corcoran</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bakiasi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Aubourg</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</string-name>
(<year>2016</year>) <article-title>Efficient derivation of microglia-like cells from human pluripotent stem cells</article-title>. <source>Nat Med</source>
<volume>22</volume>, <fpage>1358</fpage>&#x02013;<lpage>1367</lpage>.<pub-id pub-id-type="pmid">27668937</pub-id></mixed-citation></ref><ref id="ref132"><label>[132]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Abud</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Ramirez</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Healy</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>CHH</given-names>
</string-name>, <string-name>
<surname>Newman</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Yeromin</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Scarfone</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Fimbres</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Caraway</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Fote</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Madany</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Agrawal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kayed</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gylys</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Cahalan</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Cummings</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Antel</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Mortazavi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Carson</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Poon</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Blurton-Jones</surname>
<given-names>M</given-names>
</string-name>
(<year>2017</year>) <article-title>iPSC-derived human microglia-like cells to study neurological diseases</article-title>. <source>Neuron</source>
<volume>94</volume>, <fpage>278</fpage>&#x02013;<lpage>293</lpage>
<fpage>e279</fpage>.<pub-id pub-id-type="pmid">28426964</pub-id></mixed-citation></ref><ref id="ref133"><label>[133]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Juopperi</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Chiang</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Margolis</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Ming</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>H</given-names>
</string-name>
(<year>2012</year>) <article-title>Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington&#x02019;s disease patient cells</article-title>. <source>Mol Brain</source>
<volume>5</volume>, <fpage>17</fpage>.<pub-id pub-id-type="pmid">22613578</pub-id></mixed-citation></ref><ref id="ref134"><label>[134]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Brennand</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Savas</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tran</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Simone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hashimoto-Torii</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Beaumont</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Topol</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ladran</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Abdelrahim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matikainen-Ankney</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chao</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Mrksich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rakic</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yates</surname>
<given-names>JR</given-names>
<suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Gage</surname>
<given-names>FH</given-names>
</string-name>
(<year>2015</year>) <article-title>Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia</article-title>. <source>Mol Psychiatry</source>
<volume>20</volume>, <fpage>361</fpage>&#x02013;<lpage>368</lpage>.<pub-id pub-id-type="pmid">24686136</pub-id></mixed-citation></ref><ref id="ref135"><label>[135]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Mariani</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Simonini</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Palejev</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tomasini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Szekely</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Horvath</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Vaccarino</surname>
<given-names>FM</given-names>
</string-name>
(<year>2012</year>) <article-title>Modeling human cortical developmentusing induced pluripotent stem cells</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>, <fpage>12770</fpage>&#x02013;<lpage>12775</lpage>.<pub-id pub-id-type="pmid">22761314</pub-id></mixed-citation></ref><ref id="ref136"><label>[136]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Miller</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Ganat</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Kishinevsky</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bowman</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>EY</given-names>
</string-name>, <string-name>
<surname>Mandal</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Vera</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Kriks</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taldone</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fusaki</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tomishima</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Krainc</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Milner</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Studer</surname>
<given-names>L</given-names>
</string-name>
(<year>2013</year>) <article-title>Human iPSC-based modeling of late-onset disease via progerin-induced aging</article-title>. <source>Cell Stem Cell</source>
<volume>13</volume>, <fpage>691</fpage>&#x02013;<lpage>705</lpage>.<pub-id pub-id-type="pmid">24315443</pub-id></mixed-citation></ref><ref id="ref137"><label>[137]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Gunhanlar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shpak</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van der Kroeg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gouty-Colomer</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Munshi</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Lendemeijer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ghazvini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dupont</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hoogendijk</surname>
<given-names>WJG</given-names>
</string-name>, <string-name>
<surname>Gribnau</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>de Vrij</surname>
<given-names>FMS</given-names>
</string-name>, <string-name>
<surname>Kushner</surname>
<given-names>SA</given-names>
</string-name>
(<year>2018</year>) <article-title>A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells</article-title>. <source>Mol Psychiatry</source>
<volume>23</volume>, <fpage>1336</fpage>&#x02013;<lpage>1344</lpage>.<pub-id pub-id-type="pmid">28416807</pub-id></mixed-citation></ref><ref id="ref138"><label>[138]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Grealish</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Diguet</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kirkeby</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mattsson</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Heuer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bramoulle</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Van Camp</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Perrier</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Hantraye</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bjorklund</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Parmar</surname>
<given-names>M</given-names>
</string-name>
(<year>2014</year>) <article-title>Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson&#x02019;s disease</article-title>. <source>Cell Stem Cell</source>
<volume>15</volume>, <fpage>653</fpage>&#x02013;<lpage>665</lpage>.<pub-id pub-id-type="pmid">25517469</pub-id></mixed-citation></ref><ref id="ref139"><label>[139]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kikuchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Morizane</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Magotani</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Onoe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mizuma</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Takara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Okita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Parmar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>J</given-names>
</string-name>
(<year>2017</year>) <article-title>Human iPS cell-derived dopaminergic neurons function in a primate Parkinson&#x02019;s disease model</article-title>. <source>Nature</source>
<volume>548</volume>, <fpage>592</fpage>&#x02013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">28858313</pub-id></mixed-citation></ref><ref id="ref140"><label>[140]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Mansour</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Goncalves</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Bloyd</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fernandes</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Quang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Johnston</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Parylak</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gage</surname>
<given-names>FH</given-names>
</string-name>
(<year>2018</year>) <article-title>An in vivo model of functional and vascularized human brain organoids</article-title>. <source>Nat Biotechnol</source>
<volume>36</volume>, <fpage>432</fpage>&#x02013;<lpage>441</lpage>.<pub-id pub-id-type="pmid">29658944</pub-id></mixed-citation></ref><ref id="ref141"><label>[141]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Shih</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ridd</surname>
<given-names>MJ</given-names>
</string-name>
(<year>1999</year>) <article-title>Monoamine oxidase: From genes to behor</article-title>. <source>Annu Rev Neurosci</source>
<volume>22</volume>, <fpage>197</fpage>&#x02013;<lpage>217</lpage>.<pub-id pub-id-type="pmid">10202537</pub-id></mixed-citation></ref><ref id="ref142"><label>[142]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Guzman</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Sanchez-Padilla</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>
(<year>2009</year>) <article-title>Robust pacemaking in substantia nigra dopaminergic neurons</article-title>. <source>J Neurosci</source>
<volume>29</volume>, <fpage>11011</fpage>&#x02013;<lpage>11019</lpage>.<pub-id pub-id-type="pmid">19726659</pub-id></mixed-citation></ref><ref id="ref143"><label>[143]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Thompson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Barraud</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Andersson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kirik</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Bjorklund</surname>
<given-names>A</given-names>
</string-name>
(<year>2005</year>) <article-title>Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections</article-title>. <source>J Neurosci</source>
<volume>25</volume>, <fpage>6467</fpage>&#x02013;<lpage>6477</lpage>.<pub-id pub-id-type="pmid">16000637</pub-id></mixed-citation></ref><ref id="ref144"><label>[144]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>
(<year>2013</year>) <article-title>Neuronal vulnerability, pathogenesis, and Parkinson&#x02019;s disease</article-title>. <source>Mov Disord</source>
<volume>28</volume>, <fpage>41</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">22791686</pub-id></mixed-citation></ref><ref id="ref145"><label>[145]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Dolle</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Flones</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Nido</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Miletic</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Osuagwu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kristoffersen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lilleng</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Tysnes</surname>
<given-names>OB</given-names>
</string-name>, <string-name>
<surname>Haugarvoll</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bindoff</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Tzoulis</surname>
<given-names>C</given-names>
</string-name>
(<year>2016</year>) <article-title>Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease</article-title>. <source>Nat Commun</source>
<volume>7</volume>, <fpage>13548</fpage>.<pub-id pub-id-type="pmid">27874000</pub-id></mixed-citation></ref><ref id="ref146"><label>[146]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Liang</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Luby-Phelps</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>German</surname>
<given-names>DC</given-names>
</string-name>
(<year>2007</year>) <article-title>Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson&#x02019;s disease</article-title>. <source>Exp Neurol</source>
<volume>203</volume>, <fpage>370</fpage>&#x02013;<lpage>380</lpage>.<pub-id pub-id-type="pmid">17010972</pub-id></mixed-citation></ref><ref id="ref147"><label>[147]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Perier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Bender</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Garcia-Arumi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Melia</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Bove</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Laub</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Klopstock</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Elstner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mounsey</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Teismann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Prolla</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Andreu</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Vila</surname>
<given-names>M</given-names>
</string-name>
(<year>2013</year>) <article-title>Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms</article-title>. <source>Brain</source>
<volume>136</volume>, <fpage>2369</fpage>&#x02013;<lpage>2378</lpage>.<pub-id pub-id-type="pmid">23884809</pub-id></mixed-citation></ref><ref id="ref148"><label>[148]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Matsuda</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Furuta</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>KC</given-names>
</string-name>, <string-name>
<surname>Hioki</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fujiyama</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Arai</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kaneko</surname>
<given-names>T</given-names>
</string-name>
(<year>2009</year>) <article-title>Single nigrostriatal dopaminergic neurons form widely spread and highly dense al arborizations in the neostriatum</article-title>. <source>J Neurosci</source>
<volume>29</volume>, <fpage>444</fpage>&#x02013;<lpage>453</lpage>.<pub-id pub-id-type="pmid">19144844</pub-id></mixed-citation></ref><ref id="ref149"><label>[149]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Pissadaki</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Bolam</surname>
<given-names>JP</given-names>
</string-name>
(<year>2013</year>) <article-title>The energy cost of action potential propagation in dopamine neurons: Clues to susceptibility in Parkinson&#x02019;s disease</article-title>. <source>Front Comput Neurosci</source>
<volume>7</volume>, <fpage>13</fpage>.<pub-id pub-id-type="pmid">23515615</pub-id></mixed-citation></ref><ref id="ref150"><label>[150]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>
(<year>2006</year>) <article-title>Microtubule: A common target for parkin and Parkinson&#x02019;s disease toxins</article-title>. <source>Neuroscientist</source>
<volume>12</volume>, <fpage>469</fpage>&#x02013;<lpage>476</lpage>.<pub-id pub-id-type="pmid">17079513</pub-id></mixed-citation></ref><ref id="ref151"><label>[151]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Bolam</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Pissadaki</surname>
<given-names>EK</given-names>
</string-name>
(<year>2012</year>) <article-title>Living on the edge with too many mouths to feed: Why dopamine neurons die</article-title>. <source>Mov Disord</source>
<volume>27</volume>, <fpage>1478</fpage>&#x02013;<lpage>1483</lpage>.<pub-id pub-id-type="pmid">23008164</pub-id></mixed-citation></ref><ref id="ref152"><label>[152]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Trojanowski</surname>
<given-names>JQ</given-names>
</string-name>
(<year>2006</year>)<source>Neuron</source>
<volume>52</volume>, <fpage>33</fpage>&#x02013;<lpage>38</lpage>
<article-title>Mechanisms of Parkinson&#x02019;s disease linked to pathological alpha-synucle</article-title>. New targets for drug discovery.<pub-id pub-id-type="pmid">17015225</pub-id></mixed-citation></ref><ref id="ref153"><label>[153]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Brundin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Melki</surname>
<given-names>R</given-names>
</string-name>
(<year>2017</year>) <article-title>Prying into the prion hypothesis for Parkinson&#x02019;s disease</article-title>. <source>J Neurosci</source>
<volume>37</volume>, <fpage>9808</fpage>&#x02013;<lpage>9818</lpage>.<pub-id pub-id-type="pmid">29021298</pub-id></mixed-citation></ref><ref id="ref154"><label>[154]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Obeso</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Halliday</surname>
<given-names>GM</given-names>
</string-name>
(<year>2017</year>) <article-title>Parkinson&#x02019;s disease is not simply a prion disorder</article-title>. <source>J Neurosci</source>
<volume>37</volume>, <fpage>9799</fpage>&#x02013;<lpage>9807</lpage>.<pub-id pub-id-type="pmid">29021297</pub-id></mixed-citation></ref><ref id="ref155"><label>[155]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Lieberman</surname>
<given-names>OJ</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kanter</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Saverchenko</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Frier</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Fiore</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kondapalli</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zampese</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Surmeier</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mosharov</surname>
<given-names>EV</given-names>
</string-name>
(<year>2017</year>) <article-title>alpha-synuclein-dependent calcium entry underlies differential sensitivity of cultured SN and VTA dopaminergic neurons to a Parkinsonian neurotoxin</article-title>. <source>eNeuro</source>
<volume>4</volume>, <comment>ENEURO.0167-17</comment>
<fpage>2017</fpage>.</mixed-citation></ref><ref id="ref156"><label>[156]</label><mixed-citation publication-type="journal">
<string-name>
<surname>Mosharov</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Kanter</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Phillips</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Schmitz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Krantz</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Edwards</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</string-name>
(<year>2009</year>) <article-title>Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons</article-title>. <source>Neuron</source>
<volume>62</volume>, <fpage>218</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">19409267</pub-id></mixed-citation></ref></ref-list></back></article>